Discover the role of Advanced Practice Registered Nurses (APRN): highly skilled healthcare professionals providing specialized care and improving patient outcomes.

Metabolic Health: A Comprehensive Guide to Understanding Obesity & Diabetes

Understand the effects of obesity and diabetes on overall wellness and take steps towards improvement in your metabolic health.

Abstract

Hello, I’m Dr. Alex Jimenez. In this educational post, we will embark on a comprehensive journey to understand the intricate and often overlapping physiological pathways of obesity, type 2 diabetes, and cardiovascular disease. I will present a patient-centered, first-person narrative describing how I approach these conditions through an integrative lens that blends chiropractic care, functional medicine, medical oversight, and rehabilitation. Drawing on the latest evidence-based research from leading experts, we will explore why treating obesity is not a matter of willpower but of addressing deep-seated biological dysregulation. We will delve into how inflammation, insulin resistance, and hormonal imbalances form a common pathological foundation for these chronic conditions. This discussion will highlight how modern pharmacotherapy targets these underlying mechanisms and why a chronic disease management model is essential for long-term success. Furthermore, I will explain how our unique multidisciplinary practice at Injury Medical Clinic PA integrates my chiropractic and functional medicine care with medical direction from our collaborative physician to provide a holistic and powerful treatment strategy for patients grappling with these complex cardiometabolic issues. We will break down the science, examine treatment guidelines, and illustrate how a synergistic approach, through real-world patient scenarios, can lead to profound improvements in health and quality of life.

Our Integrative Team: A Multidisciplinary Powerhouse

At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas, our philosophy is rooted in collaboration and integration. We believe that the most effective patient care comes from combining the strengths of different medical disciplines. I am Dr. Alexander Jimenez, and my credentials as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), board-certified Family Nurse Practitioner (FNP-BC), and advanced certifications in Functional Medicine (CFMP, IFMCP, ATN, CCST) allow me to view patient health through a multifaceted lens. My focus is on the structural, neurological, and functional aspects of wellness.

Functional Hormone, Thyroid, and Pellet Care Solutions

A cornerstone of our practice is our collaboration with Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine with an impressive 40 years of experience (NPI #1164426749, Texas MD License #J2933). She serves as our Medical Director and Collaborative Physician, providing invaluable medical oversight, ensuring our protocols are evidence-based, and offering a deep understanding of internal medicine. This partnership between a chiropractor and an internist allows us to create a truly comprehensive care model, which is a standard and effective setup in integrative and injury care clinics.

Our team works in synergy to address the full spectrum of a patient’s needs. Here’s how our services fit together:

Medical Oversight (Dr. Cardenas, MD): Dr. Cardenas guides our medical protocols, confirms diagnoses, manages complex internal medicine conditions, reviews contraindications, and provides the necessary supervision for prescription therapies and advanced medical interventions. Her extensive experience is crucial for diagnosing and treating systemic diseases that often accompany musculoskeletal issues, such as diabetes and cardiovascular disease.
Chiropractic & Functional Medicine (Dr. Jimenez, DC, APRN, FNP-BC): I focus on restoring the body’s natural function. Through chiropractic adjustments, we can improve nervous system function, reduce pain, and enhance mobility. This is particularly important for patients with obesity, as pain can be a major barrier to physical activity. Through functional medicine, we dive deep to identify the root causes of dysfunction—be it gut dysbiosis, hormonal imbalances, or nutrient deficiencies—and create personalized plans involving nutrition, supplementation, and lifestyle changes to restore health from the inside out.
Rehabilitation & Personal Injury Care: Our team also includes specialists in physical rehabilitation who help patients recover from injuries and improve their functional capacity. This is a critical component of managing obesity, as structured exercise programs are essential for building muscle, improving metabolism, and supporting weight loss.

By integrating these disciplines, we don’t just treat symptoms; we treat the whole person. We address the structural, biochemical, and medical aspects of health simultaneously, providing a level of care far more effective than any single approach could be.

Understanding the Roots of Cardiometabolic Disease

In my clinical practice, we frequently manage conditions like dyslipidemia (abnormal blood fats), hypertension (high blood pressure), and various metabolic disorders. For decades, we have had a wide array of medications to manage the symptoms of these diseases. However, a crucial understanding has emerged from modern research: in many cases, obesity is the underlying root cause of these interconnected health problems.

Imagine a tree. The branches and leaves—the visible parts—are the diseases we commonly treat, such as heart disease, diabetes, and high blood pressure. But the roots, hidden beneath the surface, represent the foundational issue of obesity. These are the obesity-related complications and comorbidities that drive the majority of chronic diseases we face today.

The Misconception of Willpower: Obesity Causes Overeating

The human body possesses remarkably resilient, tightly regulated systems. If you become dehydrated, your kidneys conserve water, and you feel thirsty, prompting you to drink. In the same way, body weight is meant to be tightly regulated. However, in obesity, this regulatory system becomes dysfunctional. A groundbreaking shift in our understanding is this: Overeating doesn’t cause obesity; obesity causes overeating. Before a noticeable increase in fat mass (adiposity) occurs, a dysregulation of the endocrine system is already underway.

The First Hit: Hormonal Dysregulation
The process begins when something—be it genetics, environmental factors, or obesogenic medications—triggers the “on” switch for obesity. Once activated, the body’s production of hunger hormones (like ghrelin) increases, while the production of satiety hormones (like leptin and GLP-1) decreases. This creates a powerful biological drive for increased hunger and food intake.
The Second Hit: The Brain Defends a Higher Weight
The second, and perhaps more insidious, part of this pathology is that the brain begins to defend this new, higher body weight as its “normal.” This is the biological reality behind the frustrating cycle of weight regain. We now know it’s a consequence of dysregulated biology. The leading hypothesis is that this defense mechanism arises from inflammation in the hypothalamus, the brain’s control center for appetite and energy expenditure.

Obesity is an incredibly multifactorial disease, influenced by over 200 genes, endocrine-disrupting chemicals, poor sleep, and chronic stress.

The Pathophysiological Overlap of Diabetes and Heart Disease

To truly appreciate the interconnected nature of these conditions, let’s look at the underlying biology of each.

The Progression of Type 2 Diabetes

The pathophysiology of type 2 diabetes unfolds over years, beginning with insulin resistance, where cells become less responsive to insulin. To compensate, the pancreatic beta cells work overtime, producing more insulin. Eventually, these cells become exhausted, leading to impaired insulin secretion and elevated blood sugar (hyperglycemia), a condition known as prediabetes. As function declines further, type 2 diabetes is diagnosed. Beyond the pancreas, diabetes involves chronic inflammation, gut dysbiosis, and mitochondrial dysfunction, which contribute to “metabolic memory,” perpetuating the disease.

The Inflammatory Core of Cardiovascular Disease

Cardiovascular disease shares a similar common denominator: atherosclerosis, the buildup of plaque in the arteries, which is fundamentally driven by inflammation. A key player is nitric oxide (NO), a critical molecule that promotes vasodilation (widening of blood vessels) and reduces inflammation. In cardiovascular disease, nitric oxide availability decreases, leading to increased blood clotting, rampant inflammation, and endothelial dysfunction (damage to blood vessel linings). Metabolically, this leads to decreased glucose tolerance, elevated triglycerides, and increased oxidative stress.

The Unifying Theory: Inflammation, Lipotoxicity, and Mitochondrial Dysfunction

A clear picture emerges when we put it all together. The journey often begins with obesity, which fosters chronic inflammation and lipotoxicity (cellular damage from excess fats). This environment leads to mitochondrial dysfunction, impairing cellular energy production. This trifecta—inflammation, lipotoxicity, and mitochondrial dysfunction—creates a vicious cycle, driving the progression of obesity, insulin resistance, type 2 diabetes, and ultimately, cardiovascular disease.

Patient Journey: Stephen’s Case and Early Intervention for Prediabetes

To illustrate these concepts, let’s look at a patient I’ll call Stephen. His journey highlights how we apply this integrative model in practice.

Case Introduction and Risk Profile

Stephen is a 24-year-old male who sees me for follow-up regarding prediabetes and weight management. His A1C is 5.8%. He has a history of progressive weight gain, reaching a current weight of 250 lb with a BMI of 32.1 (class I obesity). His family history is significant for obesity, cardiovascular disease, and type 2 diabetes. His exam reveals central adiposity with a waist circumference of 41 inches, acanthosis nigricans, and skin tags, all signs of chronic hyperinsulinemia and insulin resistance.

From a physiological standpoint, Stephen exhibits a classic metabolic phenotype driven by:

Visceral adiposity: Central fat secretes pro-inflammatory adipokines and reduces adiponectin, impairing insulin sensitivity.
Hepatic insulin resistance: Increased liver glucose production and dyslipidemia, increasing his risk of metabolic dysfunction-associated steatotic liver disease (MASLD).
Endocrine signals: Altered leptin signaling and dysregulated GLP-1/GIP pathways that reduce satiety.
Biomechanics: Excess abdominal load increases lumbar lordosis and knee strain, areas where chiropractic integrative care can provide structural relief.

Evidence-Based Weight Loss Targets: Why Percentages Matter

I explained to Stephen that targeted weight-loss thresholds can dramatically change his health trajectory:

3% weight loss: Measurable improvements in prediabetes and insulin sensitivity.
10% weight loss: Robust changes in glucose control, lipids, and blood pressure.
15%+ weight loss: Meaningful impact on type 2 diabetes, dyslipidemia, hypertension, sleep apnea, and MASLD.

Reducing adipose tissue lowers inflammatory cytokines, restores hormonal balance, and improves insulin signaling. These targets guide our decision on whether to use lifestyle changes alone or incorporate anti-obesity pharmacotherapy.

Patient Journey: Victoria – The Intersection of Menopause, Weight Gain, and Diabetes

Now, let’s explore a case representative of what many women experience during menopause.

Initial Presentation and History

Victoria, a 52-year-old woman, came to my clinic for a follow-up on her prediabetes and recent weight gain. She had recently entered menopause and gained 15 pounds in the past year. Her job is largely sedentary, her activity level has decreased, and she suffers from poor sleep due to night sweats.

Key Clinical Details:

BMI: 31.8 (class 1 obesity)
Fat Distribution: Central adiposity, with a neck circumference of 16 inches, a risk factor for sleep apnea.
Symptoms: Hot flashes, snoring, and high stress.

The Menopausal Transition and Metabolic Disruption

Victoria’s case is a classic example of the metabolic storm that accompanies menopause. The decline in estradiol leads to a rise in LDL cholesterol, decreased insulin sensitivity, a shift toward increased body fat, and endothelial dysfunction. These changes amplify cardiovascular risk. Fortunately, menopause hormone therapy (MHT) can mitigate many of these risks.

Laboratory Findings and Diagnosis

Victoria’s lab work confirmed our concerns. Her HbA1c had risen to 7.3%, diagnosing her with type 2 diabetes. Her HOMA-IR score, a measure of insulin resistance, was 4.7, indicating significant dysfunction.

Crafting a Patient-Centered Treatment Plan

Using a shared decision-making model, I asked Victoria, “What area would you like to target first?” She chose to try a higher dose of metformin and was intrigued by the idea of using a Continuous Glucose Monitor (CGM). The CGM provides invaluable real-time feedback that drives positive behavior changes. We also referred her to a menopause specialist.

When Victoria returned, her CGM data was eye-opening. Her average glucose was 173 mg/dL, and she was spending 34% of her time in hyperglycemia. Armed with this new insight, she committed to increasing her metformin, boosting protein intake, and eliminating sugar-sweetened beverages. A month later, after starting MHT, her sleep and hot flashes improved, but her weight loss was slow. At this point, I introduced semaglutide, a GLP-1 receptor agonist. One year later, she had lost 25 pounds, her BMI dropped from 31.8 to 27.5, and her metabolic markers improved dramatically. By treating her obesity, we achieved remission of her diabetes.

Patient Journey: Banny – Addressing Long-Standing Diabetes and Cardiovascular Risk

Our next case involves Banny, a 64-year-old man with a long and complex medical history, including type 2 diabetes for 25 years, hypertension, and a previous heart attack. His weight was 230 lbs (BMI of 36), and he struggled with food cravings and uncontrolled blood pressure.

The “5 C’s” of Obesity Treatment

When evaluating Banny, I used my “5 C’s” framework: Criteria, Contraindications, Combine, Cues/Causes, and Cost/Coverage. His history of cardiovascular disease made him a prime candidate for a GLP-1 receptor agonist like semaglutide, which has been shown to reduce the risk of major adverse cardiovascular events. I framed it as a way to not only manage his diabetes and weight but also reduce his risk for a second heart attack. He was immediately on board.

Uncovering Hidden Liver Disease

Banny’s labs showed a slightly elevated liver enzyme (ALT), prompting me to calculate his FIB-4 score, a non-invasive screen for liver fibrosis. His score of 2.25 placed him at high risk. This is critical, as up to 65% of people with type 2 diabetes have Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). I referred him to a gastroenterologist for further evaluation.

One year later, Banny had lost 23 pounds, and his HbA1c improved to 5.9%. He was diagnosed with liver fibrosis and started on a new medication. However, his weight loss had plateaued, and he struggled with intense food cravings. To address this, we added a low dose of topiramate at night to help control cravings, demonstrating a multi-pronged approach to modern obesity management.

Chiropractic Care & Metabolism The Hidden Link- Video

A Unified Approach to Treatment: Beyond “Eat Less, Move More”

The treatment guidelines for obesity, diabetes, and cardiovascular disease share a common foundation: a healthy eating plan, increased physical activity, and behavioral interventions. For diabetes and heart disease, we readily use medications, yet for obesity, there’s a misguided notion that patients must first “fail” lifestyle changes. This ignores the biological reality of the disease, where metabolic adaptation fiercely defends a higher body weight. Medications for obesity directly counteract the pathological hormonal and neurological changes driving the disease.

Nutrition Strategy: Creating Sustainable Metabolic Change

For patients like Stephen, we design a sustainable, enjoyable nutrition plan. This includes:

Caloric reduction: A deficit of 500- 750 kcal daily.
Carbohydrate management: Moderating refined carbs to improve insulin signaling.
Protein prioritization: To support satiety, thermogenesis, and muscle retention.
Fiber and non-starchy vegetables: To improve glycemic control and gut microbiome diversity.

Behavioral Health Strategy: Sleep, Stress, and Mood

Chronic stress and poor sleep worsen insulin resistance and weight gain by increasing cortisol and altering ghrelin and leptin levels. We screen for and address stress, mood, and sleep disorders, such as sleep apnea.

Physical Activity: Graded Movement and Functional Capacity

I provide evidence-based recommendations, such as 150-300 minutes/week of moderate-intensity activity and resistance training at least two days a week. For patients with pain, we incorporate referrals to physical and occupational therapy.

The Role of Modern Medications

The advent of GLP-1 receptor agonists (like liraglutide and semaglutide) and dual GIP/GLP-1 agonists (like tirzepatide) has been a game-changer. These medications mimic the body’s natural satiety hormones, helping patients achieve an average weight loss of 15-20% or more. Excitingly, many of these newer drugs, along with SGLT-2 inhibitors, have demonstrated significant cardiovascular benefits.

Recent multi-year research on tirzepatide has shown it can sustain a diabetes-free status in adults with prediabetes and deliver high-magnitude weight loss. For Stephen, after reviewing his options, we selected tirzepatide, starting at 2.5 mg weekly and titrating up. Two weeks later, he had lost 3 lbs. At one year, after reaching a 15 mg weekly dose, he had lost 50 lbs, his A1C was 5.4%, and his BMI dropped to 25.7.

An important part of my job is also avoiding obesogenic medications—drugs like certain sulfonylureas, insulins, and beta-blockers that can cause weight gain.

Chiropractic Integration: How Structural Care Supports Metabolic Therapy

While pharmacological and lifestyle interventions are central, integrative chiropractic care is a foundational element of our holistic approach.

Stress Reduction and Nervous System Regulation: Chronic stress is a major driver of metabolic dysfunction. My clinical observations show that patients with central obesity often develop thoracolumbar junction stiffness. Chiropractic adjustments can influence the autonomic nervous system, helping to shift the body from a “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. This modulation can lower physiological stress, supporting better glycemic control (Jimenez, n.d.-a).
Improving Mobility and Reducing Pain: For patients like Stephen, Victoria, and Banny, joint pain and stiffness can be significant barriers to physical activity. By performing spinal and extremity adjustments, we can improve joint function, reduce pain, and make it easier for patients to engage in regular exercise. This facilitates adherence to activity prescriptions.
Optimizing Biomechanics: Correcting thoracolumbar junction dysfunction and sacroiliac joint mechanics can improve gait efficiency and reduce the energy cost of movement, making it easier for patients to increase their daily steps (Jimenez, n.d.-b).
Enhancing Sleep Quality: Alleviating neck and upper back tension can support airway mechanics and reduce nocturnal discomfort, which, in my clinical experience, can improve morning glucose stability.

The Chronic Disease Model: Why Treatment Must Be Long-Term

I want to end by reinforcing the most crucial concept: obesity is a chronic, relapsing disease that requires long-term management. The pathology of weight regain is a biological certainty, not a personal failing. When a person with obesity loses weight, the brain initiates a powerful counter-response: metabolism slows down, hunger hormones surge, and satiety hormones decrease. This creates an overwhelming drive to regain weight.

The STEP 1 trial extension starkly illustrates this: when participants stopped taking semaglutide, they began regaining weight, and their blood pressure and A1C levels started to creep back up (Wilding et al., 2022). We must apply the same chronic care model to obesity that we use for hypertension or diabetes. The goal is sustainable, long-term management to control the disease and prevent its devastating complications.

At Injury Medical Clinic, this philosophy guides us. By integrating chiropractic care to restore function, functional medicine to address root causes, and medical oversight from Dr. Cardenas to leverage the best of modern pharmacotherapy, we provide our patients with the comprehensive, long-term support they need to conquer these interconnected diseases and reclaim their health.

SEO Tags: Obesity Treatment, Type 2 Diabetes, Prediabetes Management, Cardiovascular Disease, Integrative Care, Chiropractic, Functional Medicine, Tirzepatide, GLP-1 GIP Agonists, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso Clinic, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Inflammation, Insulin Resistance, Metabolic Adaptation, Weight Regain, Cardiometabolic Health, Chronic Disease Management, Atherosclerosis, Nitric Oxide, Pharmacotherapy, Menopause and Weight Gain, Continuous Glucose Monitor, Semaglutide

References

June 10, 2026

Heat Waves and Car Accidents: El Paso Safety Guide

Extreme Heat Is More Than a Summer Problem

El Paso summers can be beautiful, but they can also be dangerous for drivers. Extreme heat does not only make people uncomfortable. It can also increase the risk of motor vehicle accidents. Scientific studies and safety reports show that hotter days and heat waves can raise the chance of crashes, injuries, and even fatal accidents.

This happens because heat affects three things at once:

The driver
The vehicle
The road environment

When a driver is tired, dehydrated, or distracted by the heat, reaction time can slow down. When a vehicle is overheated or poorly maintained, tires, batteries, brakes, and engines may fail. When the road is hot, crowded, bright, or under construction, the driving environment becomes harder to manage.

In El Paso, TX, where high temperatures can last for many weeks, drivers should treat summer heat as a real safety risk.

How Heat Increases the Risk of Car Accidents

Extreme heat can make driving more dangerous in several ways. Studies have found that high temperatures are associated with increased crash risk, especially on very hot days and during heat waves (Hsu, 2026; Gu et al., 2025). Heat can also make crashes more severe because drivers may react more slowly or make unsafe choices when they are tired or dehydrated.

Hot weather can affect drivers by causing:

Fatigue
Dehydration
Headaches
Dizziness
Blurry focus
Irritability
Slower reaction time
Poor decision-making

Heat can also affect vehicles. Tires may be more likely to fail when they are underinflated, worn down, or exposed to hot pavement. Engines can overheat. Batteries can weaken. Air conditioning systems can fail. Any of these problems can cause a driver to lose control, stop suddenly, or become stranded in dangerous traffic conditions (Jim Adler & Associates, 2025; Martinez Law Office, 2024).

This is why summer driving safety is not just about paying attention. It is also about preparing the body and the vehicle before getting on the road.

Why El Paso Drivers Should Be Extra Careful

El Paso drivers often deal with long stretches of intense sun, heavy traffic, dry heat, and hot roads. Busy areas such as I-10, Loop 375, Mesa, Montana, Zaragoza, and the East Side can become stressful during peak heat hours. When traffic slows down, the heat inside and outside the vehicle can build quickly.

Even a short drive can become risky if the driver is tired, thirsty, or overheated. A parked vehicle can also become dangerously hot in a short time. This can place children, older adults, pets, medications, and medical supplies at risk. Safety agencies warn that vehicles can heat up quickly, even with a window cracked (National Highway Traffic Safety Administration, n.d.).

For El Paso families, workers, students, veterans, and commuters, summer road safety should be part of daily planning.

Warning Signs of Heat-Related Driver Fatigue

A driver does not have to pass out to be unsafe. Heat-related fatigue can begin with mild symptoms. These early signs should not be ignored.

Watch for:

Strong thirst
Dry mouth
Heavy sweating
Headache
Dizziness
Nausea
Muscle cramps
Sleepiness
Irritability
Trouble focusing
Delayed reaction time
Drifting out of the lane
Missing traffic lights or signs

If these symptoms happen while driving, pull over in a safe place. Get into shade or air conditioning, drink water, and rest until you feel alert again. If symptoms are severe, such as confusion, fainting, chest pain, or trouble breathing, seek emergency medical care.

How to Prepare Your Vehicle for El Paso Summer Heat

Good vehicle maintenance can help prevent heat-related crashes and breakdowns. Before summer driving, drivers should check the systems that are most affected by heat.

Important summer vehicle checks include:

Tire pressure
Tire tread
Spare tire condition
Engine coolant
Oil level
Battery health
Brake condition
Air conditioning
Windshield wipers
Washer fluid
Headlights and brake lights

Drivers should also keep an emergency kit in the vehicle.

A summer driving kit may include:

Bottled water
Electrolyte packets
Phone charger
Flashlight
Jumper cables
First-aid supplies
Reflective warning triangle
Cooling towel
Sunscreen
Sunglasses
Basic tools

A windshield shade can also help lower the temperature inside a parked vehicle. If possible, park in shaded areas and allow the vehicle to cool before driving.

Safe Driving Habits During Extreme Heat

During a heat wave, simple choices can make driving safer.

Helpful tips include:

Drink water before driving
Avoid driving while tired
Eat light meals before long drives
Avoid alcohol before driving
Cool the vehicle before starting a trip
Take breaks on long drives
Avoid peak heat hours when possible
Leave extra space between vehicles
Watch for stalled vehicles
Do not ignore dashboard warning lights
Slow down in construction zones
Avoid aggressive driving

Heat can make people impatient. When traffic is slow and temperatures are high, drivers may tailgate, speed, or make sudden lane changes. Staying calm and leaving extra space can help prevent rear-end crashes and side-impact accidents.

What Happens to the Body During a Motor Vehicle Accident?

A motor vehicle accident can place sudden force on the body. Even a low-speed crash can injure muscles, ligaments, joints, discs, nerves, and soft tissue. Many injuries happen because the body moves faster than it can protect itself.

Common accident-related injuries include:

Whiplash
Neck sprains
Back strains
Disc irritation
Shoulder injuries
Hip pain
Sciatica
Headaches
Muscle spasms
Numbness or tingling
Joint stiffness
Dizziness
Fatigue

Symptoms may appear right away or show up hours or days later. This delay can happen because adrenaline can hide pain at first. A person may feel “okay” at the scene but wake up the next morning with neck pain, back pain, headaches, or stiffness.

That is why it is important to be checked after an accident, even if the crash seems minor.

Why Integrative Care Can Help After an MVA

After a car accident, the body may need more than one type of care. Pain may come from spinal joints, muscles, ligaments, nerves, inflammation, poor posture, or guarded movement. An integrative clinic can look at the whole person rather than focusing on a single symptom.

At ChiroMed – Integrated Medicine in El Paso, the care model focuses on whole-person injury recovery. ChiroMed’s public materials describe a multidisciplinary approach that may include chiropractic care, nurse practitioner services, rehabilitation, nutrition, naturopathic medicine, acupuncture, and integrative medicine support (ChiroMed, n.d.).

This type of approach may help patients who are dealing with:

Neck pain after a crash
Back pain after a crash
Headaches after whiplash
Muscle spasms
Reduced range of motion
Nerve symptoms
Fatigue after injury
Poor sleep after trauma
Trouble returning to work or daily activities

The goal is not just short-term pain relief. The goal is to help restore movement, reduce irritation, support healing, and improve function.

ChiroMed’s Multidisciplinary Injury Care Model

ChiroMed’s patient-centered approach is built around coordinated care. Instead of treating the spine, muscles, nerves, and general health as separate issues, the team looks at how these systems work together.

This can include:

Chiropractic evaluation
Spinal and joint care
Soft tissue work
Functional movement assessment
Rehabilitation exercises
Nutrition and lifestyle support
Functional medicine insights
Medical oversight when needed
Personal injury documentation

For accident patients, this matters because injuries often overlap. A patient may have neck pain, low back pain, headaches, sleep problems, inflammation, and stress simultaneously. A coordinated plan can help connect these symptoms to the crash and guide the patient through recovery.

Medical Oversight With Dr. Maria Guadalupe Cardenas, MD

A strong integrative clinic also needs medical oversight. Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, serves as Medical Director and Collaborative Physician with Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas. Clinic materials list Dr. Cardenas with NPI #1164426749 and Texas MD License #J2933. She brings more than 40 years of experience as an internist (ChiroMed, 2026).

In this model, Dr. Cardenas provides internal medicine oversight while Dr. Alex Jimenez, DC, APRN, FNP-BC, leads chiropractic, functional medicine, rehabilitation, and personal injury care. This type of collaboration supports safe, organized, and scope-aware care for patients recovering from accidents.

Medical oversight is especially helpful when a patient has:

High blood pressure
Diabetes
Heart disease risk
Medication concerns
Dizziness
Severe fatigue
Complex pain
Chronic inflammation
Multiple injuries
Older age
Previous health conditions

This helps the team make safer decisions and recognize when a referral, imaging study, or additional medical evaluation may be needed.

Dr. Alex Jimenez’s Clinical Approach to Accident Recovery

Dr. Alexander Jimenez, DC, APRN, FNP-BC, has long focused on injury care, chiropractic care, functional medicine, and personal injury recovery in El Paso. His clinical observations often highlight that motor vehicle accidents can affect multiple areas of the body.

A crash may cause:

Spinal misalignment
Muscle guarding
Ligament strain
Nerve irritation
Joint restriction
Inflammation
Poor posture
Headaches
Fatigue
Reduced mobility

From a ChiroMed care perspective, recovery should be guided by a careful exam, clear documentation, and a plan that matches the patient’s needs. This may include chiropractic care, rehabilitation, functional medicine support, and medical collaboration when appropriate.

For example, a patient with whiplash may need neck mobility work, soft tissue care, postural correction, and strengthening. A patient with low back pain may need evaluation for disc irritation, hip restriction, sacroiliac joint involvement, or nerve symptoms. A patient with headaches may need assessment of the neck, upper back, jaw tension, sleep, hydration, and stress response.

Tailored Recovery Strategies After a Heat-Related MVA

If you are involved in a crash during extreme heat, the first step is safety. Move to a safe location if possible. Call emergency services if anyone is hurt. Get medical attention if symptoms are severe.

After the emergency stage, recovery may include:

A full injury evaluation
Chiropractic exam
Neurological screening
Range-of-motion testing
Muscle and joint assessment
Imaging when clinically needed
Gentle movement care
Soft tissue therapy
Rehab exercises
Hydration support
Anti-inflammatory nutrition
Sleep support
Follow-up visits to track progress

The care plan should change as the patient improves. Early care may focus on pain, stiffness, and inflammation. Later care may focus on strength, posture, balance, endurance, and return to daily activities.

When to Seek Immediate Medical Care

Some symptoms after a motor vehicle accident should be treated as urgent.

Seek emergency care if you have:

Loss of consciousness
Severe headache
Confusion
Chest pain
Trouble breathing
Severe neck pain
Severe back pain
Weakness in the arms or legs
Numbness that is getting worse
Loss of bladder or bowel control
Vision changes
Severe dizziness
Vomiting
Abdominal pain
Signs of heat illness

These symptoms may point to serious injury or heat-related illness and should not be ignored.

What to Look for in an El Paso MVA Clinic

After an accident, look for a clinic that understands both injury recovery and proper documentation.

Helpful qualities include:

Experience with motor vehicle accident injuries
Chiropractic and rehabilitation services
Medical oversight or collaboration
Clear exams and progress notes
Functional movement assessment
Patient education
Referral coordination
Whole-person recovery planning
Personal injury experience

At ChiroMed – Integrated Medicine, the focus is on helping patients understand their injuries, improve movement, and support recovery through coordinated care.

Final Thoughts: Protect Yourself Before and After the Crash

Extreme heat can raise the risk of car accidents in El Paso. Heat can affect the driver’s focus, the vehicle’s performance, and road safety. Preparing your vehicle, staying hydrated, recognizing heat fatigue, and driving with patience can reduce your risk.

If a crash happens, do not ignore symptoms like neck pain, back pain, headaches, stiffness, dizziness, numbness, or fatigue. These symptoms may be signs of deeper injury.

ChiroMed – Integrated Medicine in El Paso offers a multidisciplinary path for accident recovery. With Dr. Alex Jimenez, DC, APRN, FNP-BC, providing chiropractic, functional medicine, rehabilitation, and personal injury care, and Dr. Maria Guadalupe Cardenas, MD, providing medical direction and internal medicine oversight, patients can receive a broader and more coordinated approach to healing.

References

Accident & Injury Chiropractic. (n.d.). High temperatures and car crashes

Accident Centers of Texas. (n.d.). Road to recovery: How chiropractic care helps in healing spinal injuries after motor vehicle accidents

Callahan Law Firm. (2025). Do heat waves increase the chances of auto accidents?

ChiroMed. (n.d.). ChiroMed – Integrated Medicine holistic healthcare in El Paso, TX

ChiroMed. (2026). Integrative care for spine, joint, and muscle pain

DeMayo Law Offices. (2025). A study considering the significant effects of hot weather on road accident statistics

Gu, Z., Peng, B., & Xin, Y. (2025). Higher traffic crash risk in extreme hot days? A spatiotemporal examination of risk factors and influencing features

Health Coach Clinic. (n.d.). Auto accident recovery with functional medicine guide

Health Coach Clinic. (n.d.). Chiropractic integrative care for motor vehicle accidents

Health Coach Clinic. (n.d.). Integrative medicine approach: Healing after accidents

Hsu, C. K. (2026). Extreme heat disproportionately increases severe road traffic injuries

Jim Adler & Associates. (2025). How extreme heat and car accidents are connected

Jimenez, A. (n.d.). El Paso, TX chiropractor Dr. Alex Jimenez DC: Personal injury specialist

Jimenez, A. (n.d.). Prevent drowsy driving accidents with energy foods

Jimenez, A. (2025). Recovering from car accidents: A holistic approach with functional medicine and chiropractic care

Martinez Law Office. (2024). Car accidents and the heat: Why the heat makes accidents worse

National Highway Traffic Safety Administration. (n.d.). Child heatstroke prevention: Prevent hot car deaths

Rodriguez & Associates. (n.d.). Common heat-related car accidents

Scientific American. (2023). Hotter days are increasing car crashes and fatalities

June 9, 2026

PRP Therapy: A Revolutionary Approach For Joint Care

Discover the advantages of PRP therapy for joint care in promoting healing and alleviating joint pain effectively.

Abstract

In this educational post, I share a first-person reflection on the evolving landscape of orthobiologics and integrative musculoskeletal care—where precision medicine, functional rehabilitation, and chiropractic methods come together under robust medical oversight. I summarize key take-home insights from recent collaborative discussions with leading researchers and clinicians, including the roles of platelet-rich plasma (PRP), cellular therapies, photobiomodulation, and outcome-driven standardization. I also describe how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, integrates chiropractic care with internal medicine, functional medicine, and personal injury services. Under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), we align evidence-based protocols with individualized patient selection, whole-joint strategies, and rigorous data collection. The following sections outline the physiological foundations, practical techniques, and real-world clinical workflows that move patients from pain toward restored function in a structured, collaborative, and patient-centered way.

My Journey in Orthobiologics and Integrative Care

As Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I have spent decades treating musculoskeletal injuries, complex pain, and movement disorders through a combination of chiropractic science, functional medicine, and rehabilitation. What has become increasingly clear in recent years is that orthobiologics—therapies that harness the body’s biological resources to heal—are transforming how we approach musculoskeletal injury and degeneration. This is a journey; it requires curiosity, collaboration, and a commitment to both nuance and rigor.

I value small-group, high-clarity, detail-rich conversations where clinicians dissect the “how” and “why” of treatments—PRP preparation variables, cellular therapy indications, dose-response nuances in photobiomodulation, and the biomechanics of joint integration. These exchanges help us push the field forward responsibly. In the last five years, the pace of progress has been remarkable—yet tempered by adherence to data, safety, and ethical boundaries. Our work is a living synthesis of evidence and clinical experience, constantly refined by patient outcomes.

Multidisciplinary Integration: Chiropractic Care With Internal Medicine Oversight

Our practice is a multidisciplinary setup typical of integrative injury clinics. At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, I collaborate closely with Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749; Texas MD License #J2933), who serves as Medical Director and Collaborative Physician. With over 40 years of experience as an internist, Dr. Cardenas provides critical medical oversight to ensure safety, precision, and continuity of care in complex cases.

Dr. Cardenas’ role:
- Provides medical direction for patient evaluation, risk stratification, and comorbidity management.
- Oversees the appropriateness and safety of orthobiologic procedures and adjunctive therapies.
- Coordinates diagnostics, pharmacotherapy when indicated, and inter-specialty referrals.
My role (Chiropractic and Functional Integrator):
- Performs detailed musculoskeletal examinations and biomechanical analyses.
- Delivers integrative chiropractic care: spinal and extremity joint adjustments, soft tissue work, neuromuscular re-education, and kinetic chain balancing.
- Implements functional medicine strategies: inflammation modulation, mitochondrial support, nutrition, sleep optimization, stress tools.
- Coordinates rehabilitation: graded activity, sensorimotor retraining, strength sequencing, fascial mobility, and return-to-function planning.

This alignment bridges the gap between biologic therapies and functional restoration. By combining medical oversight, chiropractic biomechanics, and functional medicine, we ensure that each patient’s plan is safe, personalized, and outcome-focused.

Evidence-Based Take-Home Insights: The Seven Core Themes

From our latest collaborative dialogues with colleagues in orthobiologics and rehabilitation science, seven take-home insights emerged. Each has strong physiological rationale and clinical utility.

1. PRP and Cellular Therapies: Start Strong and Get It Right

Why PRP matters:
- Platelet-Rich Plasma (PRP) concentrates growth factors (PDGF, TGF-β, VEGF, IGF-1) and bioactive cytokines that modulate inflammation, angiogenesis, cellular migration, and extracellular matrix (ECM) synthesis. When properly prepared, PRP can enhance tenocyte and chondrocyte activity, potentially improving tendon integrity and cartilage homeostasis.
Physiology:
- Platelets release alpha-granule contents upon activation, initiating a controlled cascade that recruits reparative cells, modulates NF-κB signaling, and promotes collagen maturation.
- Leukocyte concentration influences the inflammatory profile: Leukocyte-poor PRP can be beneficial for intra-articular environments where excessive inflammation risks chondrotoxicity; Leukocyte-rich PRP may be more suitable for tendinopathies where a stronger inflammatory kick-start is appropriate.
Clinical tactics:
- Standardize spin protocols, anticoagulants, and activation steps to reduce variability in growth factor profiles.
- Tailor PRP composition to tissue target: joint vs tendon vs ligament.
- Combine PRP with integrative chiropractic joint optimization to create mechanical environments conducive to biologic healing—aligned joint surfaces, normalized load distribution, and restored neuromuscular control.

2. The Future Is Collaborative, Evidence-Based, and Hopeful

Research momentum:
- Modern orthobiologic research uses controlled clinical trials, registry data, cell counting, proteomics, and imaging to clarify mechanisms and outcomes.
- Collaboration drives innovation—clinicians share protocols, troubleshoot failures, and co-develop standards.
Why hope is justified:
- Incremental evidence is accumulating: improved pain and function for tendinopathy, early osteoarthritis, and select ligament injuries when biologics are integrated with biomechanics and rehabilitation.
Integrative chiropractic role:
- By restoring joint mechanics, we reduce aberrant shear and compressive forces, allowing biologically stimulated tissues to heal under optimal loading conditions.

3. Patient Selection and Precision Medicine: Matching the Right Patient to the Right Therapy

Core principle:
- Patient selection determines success. We assess biological age, metabolic health, systemic inflammation, nutritional status, sleep quality, and psychosocial resilience—all of which influence healing capacity.
Precision components:
- Biologic staging of joint disease (cartilage thickness, synovitis, bone marrow edema).
- Comorbidity screening (diabetes, obesity, autoimmune disease, smoking) and risk mitigation.
- Movement profiling: gait, kinetic chain imbalances, scapulothoracic rhythm in shoulder cases, pelvic tilt and lumbar mechanics for spine and hip.
Why it matters:
- Biologics require a responsive milieu. If systemic inflammation, biomechanical overload, or nutrient deficits persist, biologic effects can be muted.
Team function:
- Dr. Cardenas aligns medical management—glucose control, lipid optimization, antihypertensive strategy, and evaluation of medication interactions—with our chiropractic and rehab team, who remodel movement and load.

4. Treat the Whole Joint: The Joint as an Organ

Concept:
- A joint is an integrated organ system of cartilage, subchondral bone, synovium, ligaments, menisci/labrum, capsule, neurosensory feedback, and surrounding musculature and fascia. Isolated treatment misses the interdependence.
Physiological rationale:
- Synovial inflammation alters cartilage metabolism and subchondral perfusion; malalignment drives focal overload and microdamage; motor control deficits create repetitive strain and poor proprioceptive input.
Clinical approach:
- Alignment: Chiropractic adjustments and mobilizations to restore joint kinematics and stacking.
- Soft tissue: Myofascial release, instrument-assisted techniques, and eccentric loading programs to normalize tension and ECM remodeling.
- Neuromuscular retraining: Sensorimotor drills for joint position sense and dynamic stabilization.
- Biologic therapy integration: Intra-articular PRP timed with rehabilitation phases to leverage anabolic windows.

5. Biology Is King: Root-Cause Meets Tissue Microenvironment

Meaning:
- Biological milieu controls outcomes. Micronutrient sufficiency, mitochondrial function, glycation status, redox balance, and endocrine health set the tone for healing capacity.
Mechanisms:
- Mitochondria govern energy supply for ECM synthesis. Excess reactive oxygen species (ROS) impairs collagen cross-linking and chondrocyte function. Insulin resistance increases AGEs (advanced glycation end-products), stiffening collagen and impairing tendon elasticity.
Functional medicine integration:
- Nutritional protocols: omega-3 fatty acids, vitamin D sufficiency, magnesium, collagen peptides, and targeted phytonutrients for inflammation resolution.
- Sleep and circadian alignment improve hormone balance (GH, cortisol rhythms) and tissue repair.
- Stress modulation: autonomic balance impacts microvascular perfusion and inflammatory cytokine expression.
Chiropractic synergy:
- Restoring autonomic balance via spinal care, breath mechanics, and mobility reduces sympathetic overdrive and facilitates tissue-level repair.

6. Standardization and Outcomes Data: Protocols That Scale and Improve

Why standards:
- Standardization reduces variability, enhances reproducibility, and speeds learning across clinics.
Practical steps:
- Document PRP preparation details: hematocrit, platelet count, leukocyte fraction, activation method, volume, injection site, and ultrasound guidance.
- Maintain registries—collect PROMs (pain scales, KOOS/HOOS, DASH), functional metrics (range of motion, strength benchmarks), and imaging outcomes where appropriate.
- Perform cell counts and, when possible, protein profiling to understand dose-biologic relationships.
Data-driven iteration:
- Aggregated outcomes allow protocol refinement—adjusting PRP concentrations, pairing with specific rehab phases, and identifying subgroups that respond best.
Our practice:
- We contribute to registry efforts and encourage peer clinics to share de-identified data to accelerate the field’s maturity.

7. Photobiomodulation and Optimization: Fine-Tuning the Repair Environment

Role of photobiomodulation (PBM):
- Low-level light therapy can modulate cytochrome c oxidase, enhancing mitochondrial respiration, promoting ATP production, and influencing NO release and microcirculation. This supports the energy demands of tissue repair.
Optimization concept:
- “Sell emac photo optimizations” refers to optimizing cellular photo-responsiveness—adjusting wavelength, dose, and timing to match tissue type and healing stage.
Integration:
- Post-PRP phases may benefit from PBM to reduce pain, modulate inflammation, and support fibroblast and chondrocyte activity.
Chiropractic interface:
- PBM complements neuromuscular re-education—reduced pain facilitates higher-quality motor retraining and better load adherence.

Beyond Medicine: The Power of Chiropractic Care- Video

How Our Team Coordinates Care: From Intake to Restoration

Comprehensive Patient Intake and Stratification

Medical screening by Dr. Cardenas:
- Reviews cardiovascular, endocrine, metabolic, and autoimmune status.
- Orders labs: CBC, metabolic panel, HbA1c, CRP/ESR, vitamin D, ferritin, lipid profile.
- Evaluates medication interactions (e.g., NSAIDs around biologic procedures).
Musculoskeletal and functional assessment by my team:
- Posture, gait, joint ROM, segmental motion analysis, palpation, dynamic tests.
- Imaging when indicated: ultrasound for tendon integrity and guidance; X-ray/MRI for joint structure.

Personalized Plan: Biologics, Chiropractic, and Rehabilitation

Biologic layer:
- PRP or cellular options are selected based on pathology and patient biology.
- Ultrasound-guided injections to enhance accuracy and safety.
Chiropractic layer:
- Targeted adjustments to restore segmental motion, improve joint mechanics, and relieve compensatory strain.
- Soft tissue techniques to normalize myofascial dynamics.
Functional medicine layer:
- Nutrition, sleep hygiene, stress resilience, supplementation, and metabolic optimization.
Rehabilitation:
- Phase-based programming:
  - Phase 1: Pain modulation, gentle mobility, PBM.
  - Phase 2: Tissue loading initiation—eccentric and isometric work.
  - Phase 3: Strength integration—closed-chain stability, proprioception.
  - Phase 4: Return-to-sport/work—task-specific drills and load progression.

Outcome Tracking and Iteration

Data collection:
- Patient-reported outcomes, functional measures, and re-imaging when clinically indicated.
Iteration:
- Modify PRP concentration, adjust rehab intensity, refine chiropractic techniques based on biofeedback and progress.
Education:
- We educate patients on the “why” behind each step to increase adherence and empower self-care.

Physiological Underpinnings: Why Each Technique Works

PRP and cellular therapies:
- Growth factor-mediated chemotaxis and ECM synthesis, modulation of inflammatory pathways (e.g., NF-κB), stimulation of resident progenitor cells.
Chiropractic adjustments:
- Normalize joint play and reduce nociceptive input; improve mechanotransduction; restore load distribution to limit microdamage accumulation.
Soft tissue work:
- Break down aberrant cross-linking, encourage realignment of collagen fibers, and improve local perfusion and lymphatic flow.
Neuromuscular re-education:
- Enhance proprioceptive acuity, integrate cortical motor patterns, reduce co-contraction inefficiencies.
Functional medicine:
- Support mitochondrial ATP production, moderate inflammatory tone, correct nutrient deficits essential for collagen synthesis (proline, glycine, vitamin C), and upregulate antioxidant defenses (glutathione system).
Photobiomodulation:
- Upregulates cytochrome c oxidase activity, increases ATP levels, modulates NO-mediated vasodilation, and reduces pain signaling through downstream neuroimmune effects.

Collaboration, Standardization, and the Road Ahead

Our collective message is simple: this is a shared journey. Advancements flourish when clinicians collaborate and standardize, when we respect biology and align mechanics, and when we measure outcomes rigorously. As registry data grows and protocols are refined, we anticipate clearer guidance on dosage, timing, and patient subgroups—transforming hopeful beginnings into reliable, scalable care models.
Our clinic remains committed to:

Standardized PRP preparation and documentation.
Integration of chiropractic biomechanics with biologic therapies.
Functional medicine strategies to sustain healing capacity.
Registry participation to contribute to the broader evidence base.
Patient-centered education that turns complex science into actionable steps.

Clinical Observations and Practice Philosophy

My clinical observations over years of practice emphasize that sustained recovery emerges when we harmonize biology with biomechanics. Adjustments without biological support may underdeliver in degenerative contexts; biologics without mechanical correction often falter under continued overload. It is the pairing—precise biologic stimulation with optimized joint function and neuromuscular control—that creates a durable healing platform.
You can explore more about my clinical approach and ongoing integrative work:

ChiroMed profile: https://chiromed.com/
Professional insights and updates: https://www.linkedin.com/in/dralexjimenez/

Summary: A Unified, Patient-Centered Path

I reflected on key themes shaping modern orthobiologic and integrative care:

Start strong with well-prepared PRP or cellular therapies, tailored to tissue needs.
Embrace collaboration as the engine of progress—share protocols and data.
Apply precision medicine—choose the right therapy for the right patient.
Treat the joint as an organ—align anatomy, mechanics, and biology.
Honor the principle that biology is king—optimize the microenvironment.
Standardize protocols and capture outcomes—let data guide growth.
Utilize photobiomodulation and related optimizations to support tissue repair.

Together—with medical leadership from Dr. Maria Guadalupe Cardenas and integrative chiropractic strategies—we provide a structured, evidence-informed path for patients recovering from injury and navigating musculoskeletal disease. The future is bright because we are building it on the solid ground of biology, biomechanics, and shared knowledge.

References

Orthobiologics and musculoskeletal healing: mechanisms and clinical advances (Jimenez, A., n.d.). ChiroMed.
Dr. Alex Jimenez professional profile and clinical insights (Jimenez, A., n.d.). LinkedIn.

SEO tags: orthobiologics, PRP, platelet-rich plasma, integrative chiropractic care, functional medicine, personal injury clinic, musculoskeletal rehabilitation, photobiomodulation, internal medicine oversight, multidisciplinary clinic, El Paso Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, patient selection, precision medicine, joint as organ, standardized protocols, outcomes registry, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas

June 9, 2026

Photobiomodulation for Pain Relief and Recovery

Abstract

This educational article explores the profound cellular mechanisms behind Photobiomodulation Therapy (PBMT), often known as laser therapy, and its transformative potential in modern medicine. From a first-person perspective, I will guide you through the scientific journey of how light energy interacts with our cells to promote healing, reduce inflammation, and restore function. We will delve into the latest findings from leading researchers, explaining how PBMT activates mitochondria, modulates cytokine responses, and stimulates tissue regeneration across nerves and muscles. This post will also illuminate the synergistic relationship between PBMT and orthobiologics such as Platelet-Rich Plasma (PRP), demonstrating how combining these therapies can enhance clinical outcomes. Finally, I will explain how we integrate these advanced modalities at our clinic, where a multidisciplinary team approach, featuring integrative chiropractic care alongside medical oversight, provides a comprehensive and evidence-based path to recovery for our patients.

A Personal Journey into the Power of Light

After nearly a decade in this field, I feel like I’ve finally found my people. For years, mentioning the word “laser” in medical circles felt like an uphill battle. I faced skepticism and resistance—metaphorical rotten tomatoes and broken beer bottles for the first five years. Many of you in the regenerative medicine space can likely relate to that struggle. Pushing the boundaries of biologic-based therapies has been a similar journey. That’s why I am so thrilled to have the opportunity to share my experience and the powerful science that has not only vindicated this work but is now revolutionizing how we approach healing.

It all begins with a fundamental biological principle we often overlook: photosynthesis. The sun shines, plants grow, and they sustain life on our planet. We, as a species, have evolved over hundreds of thousands of years under that very sun. Our cells, down to their deepest genetic components, have developed a sensitivity to light.

Think about it this way: from our first days in medical school, we are taught that sunlight is essential for vitamin D synthesis. We accept this without question. Yet a significant gap exists in modern medical education regarding the broader therapeutic applications of light—a field known as Photobiomodulation Therapy (PBMT). This post is my effort to bridge that gap and explain how we can harness light to unlock the body’s innate ability to heal itself.

Our Integrative Approach at Injury Medical Clinic

At our practice, Injury Medical Clinic PA, we believe in a team-based, patient-centered model. My role as a Doctor of Chiropractic (DC) with advanced training as a Nurse Practitioner (APRN) and in Functional Medicine (CFMP, IFMCP) is to focus on the biomechanical, neurological, and metabolic aspects of health. I am privileged to work alongside Dr. Maria Guadalupe Cardenas, MD, a Board-Certified Internist with over 40 years of invaluable experience. Dr. Cardenas serves as our Medical Director and Collaborative Physician, providing essential medical oversight and ensuring our patients receive comprehensive, integrated care.

This multidisciplinary setup allows us to blend the best of different worlds:

Chiropractic Care: We address musculoskeletal alignment, nerve function, and biomechanics to restore the body’s structural integrity.
Medical Oversight: Dr. Cardenas provides the medical diagnosis, management, and direction necessary for complex cases, especially in personal injury and chronic disease.
Functional Medicine: We investigate the root causes of dysfunction, considering genetics, lifestyle, and environmental factors to develop personalized treatment plans.
Advanced Therapies: We incorporate cutting-edge modalities like Photobiomodulation (PBMT) and orthobiologics to accelerate healing at the cellular level.

This collaborative environment ensures that when we recommend a therapy like PBMT, it is part of a holistic strategy designed to treat the whole person, not just the symptom.

What is Photobiomodulation? Understanding the Language of Our Cells

Let’s break down the term:

Photo: Light
Bio: Life
Modulation: To affect or change

Photobiomodulation is the process of using light to create a biological change. We know that light is energy, and its fundamental units are photons. Think of photons as the currency of light energy. When these photons penetrate our tissues, they transfer their energy to our cells, initiating a cascade of biological responses.

For the first twenty years of my practice, I was a mechanic, using tools to “fix” conditions. For the last ten, I have become more of a biologist, focused on creating the right environment for the body’s own cells to orchestrate a healing response. Cellular recovery is the goal, and this is where PBMT truly shines.

The Cellular Mechanisms: From Mitochondria to Tissue Repair

Everyone is talking about mitochondrial health and ATP production, but the effects of PBMT go much deeper. Let’s explore the documented cellular reactions that translate into the clinical outcomes we see every day—less pain in the shoulder, knee, or elbow.

1. Mitochondrial Activation and Energy Production

The primary target of PBMT within our cells is an enzyme in the mitochondria called cytochrome C oxidase. This enzyme is a photoacceptor, meaning it is specifically designed to absorb light. When photons of the correct wavelength strike this enzyme, it becomes more active. This supercharges the Krebs cycle, leading to several critical downstream effects:

Increased ATP Production: The cell’s energy currency is produced in greater abundance, providing the fuel needed for repair and function.
Modulation of Reactive Oxygen Species (ROS): While high levels of ROS cause oxidative stress, a transient, controlled increase acts as a crucial signaling molecule.
Release of Nitric Oxide: Light can displace nitric oxide bound to cytochrome c oxidase, allowing oxygen to bind more efficiently and increasing cellular respiration. The released nitric oxide then acts as a vasodilator, improving local blood flow.

This initial spark in the mitochondria triggers a cascade that sends messages all the way to the cell’s nucleus, initiating gene transcription. This is how the cell starts producing the proteins and signaling molecules—cytokines—that direct the healing process.

2. Immune Modulation: Shifting from Inflammation to Repair

When you sustain an injury, your body floods the area with pro-inflammatory cytokines to kickstart the healing process. However, in chronic conditions, this inflammatory state can become “stalled,” preventing true recovery. PBMT helps modulate this immune response.

We can scientifically document that PBMT, using the right wavelength and dose, can:

Increase anti-inflammatory cytokines, such as interleukin-10 (IL-10).
Reduce pro-inflammatory cytokines, such as interleukin-6 (IL-6).

Essentially, PBMT helps guide the body out of the persistent inflammatory phase and into the reparative, healing phase.

3. Enhancing Blood Flow and Nerve Regeneration

The benefits continue to cascade through the body’s systems:

Angiogenesis: PBMT has been shown to stimulate angiogenesis by promoting the production of cytokines, including galectin-1. Improved microcirculation is fundamental for delivering oxygen and nutrients to damaged tissue and removing waste products.
Neurogenesis: We can even see improvements at the neuronal level. Studies have demonstrated that PBMT can upregulate proteins like hnRNP K, which are involved in axonal growth and neuronal repair. This is why it’s so effective for nerve-related pain and injury recovery.

4. Accelerating Muscle and Connective Tissue Recovery

Muscle Recovery: Using electron microscopy, researchers have confirmed that PBMT improves muscle cell development and increases myoglobin production, thereby enhancing oxygenation and speeding recovery after exertion or injury.
Fibroblast Activation: Fibroblasts are the body’s master builders, responsible for producing collagen and forming the structural framework for tissue repair. PBMT provides the energy these cells need to activate and get to work, which is why it pairs so well with orthobiologics that send the initial “go” signal.

By targeting these fundamental cellular processes, PBMT doesn’t just treat conditions like tendonitis or arthritis; it also treats the dysfunctional cells within the pathological tissue. It changes the cellular environment to one that fosters healing. That’s why it has such a broad range of applications for anything that ends in “-itis.”

The Science of Light: Wavelength, Penetration, and the Therapeutic Window

Not all light is created equal. The electromagnetic spectrum ranges from deadly gamma rays with very short wavelengths to harmless radio waves with very long wavelengths. There is a specific “therapeutic window” for PBMT, typically between 600 nanometers (red light) and 1200 nanometers (near-infrared light).

Why is this range so important? It’s all about penetration. To be effective, photons must reach the target tissue. Three primary obstacles stand in their way: skin, blood (hemoglobin), and water. The wavelengths within the therapeutic window are most adept at bypassing these absorbers and penetrating deep into the body, where musculoskeletal injuries reside.

Red light (around 600-700 nm) is excellent for superficial tissues. It penetrates only a few millimeters, making it great for skin conditions, but it won’t reach deep muscles or joints.
Near-infrared light (around 800-1100 nm) penetrates much deeper, making it the workhorse for orthopedic and musculoskeletal conditions.

At our clinic, we use advanced systems like MLS (Multiwave Locked System) Laser Technology. I am a huge fan of this technology because it synchronizes two different wavelengths—one continuous and one pulsed. The pulsed wavelength, which fires thousands of times per second, allows the tissue to absorb light energy without building up excessive heat. This makes the treatment incredibly safe and effective, allowing for unattended application without the risk of thermal damage.

The Clinical Applications: From Acute Injury to Chronic Pain

In my practice, which includes serving as a team physician for a Division I school, we use PBMT across a spectrum of conditions:

Acute Injuries: For our athletes, PBMT is a go-to for sprains, strains, and contusions. It significantly reduces recovery time and gets them back on the field faster.
Post-Operative Recovery: Surgery is, in essence, a controlled acute injury. We use PBMT postoperatively to reduce swelling, bruising, and pain, resulting in cleaner incisions and significantly improved patient-reported outcomes.
Chronic Inflammatory Conditions: For issues such as a thickened Achilles tendon or degenerative joint disease, where the inflammatory process is stalled, PBMT can reignite the healing cascade.

The evidence is overwhelming. With over 7,000 published studies, PBMT is gaining recognition from major health organizations. The Centers for Disease Control (CDC) mentions “laser photobiomodulation” dozens of times in its revised opioid guidelines as a non-pharmacological option for acute, subacute, and chronic pain. The science is no longer theoretical; it’s a clinical reality.

The Ultimate Synergy: Combining PBMT with Orthobiologics

This is where the magic truly happens. Orthobiologics like Platelet-Rich Plasma (PRP) are rich in growth factors and anti-inflammatory proteins. They are a powerful message sent to the site of injury, instructing the local cells to begin the repair process.

Now, imagine giving those cells the fuel they need to carry out those instructions. That is what PBMT does.

Orthobiologics provide the blueprint (the message).
PBMT provides the energy (the fuel).

By combining these two therapies, we are creating the optimal environment for cellular activity, healing, and regeneration. People are starting to talk about this synergy. A landmark study in the veterinary world—where patients don’t have secondary gain or placebo effects—provided powerful proof (Ferreira et al., 2021). In this canine study on knee osteoarthritis, dogs were treated with PBMT alone, then PRP alone, and finally a combination of both. The results were clear: the combination therapy produced significantly better outcomes.

The Future is Biology: A Glimpse into Our Research

We are committed to contributing to this growing body of evidence. I’m incredibly proud to share a “proud dad moment.” My son, Zachary, recently completed a study at the Mass General Brigham Enable BioSkills Lab. We took human tenocytes (tendon cells) and applied our laser over them.

The results were astounding: we demonstrated a 20% dose-dependent increase in tenocyte proliferation from PBMT alone.

We are literally proving that we can make tendon cells multiply with light. Our next steps involve qPCR to analyze gene expression and ELISA to measure protein levels. This research helps us move from anecdotal success to hard, reproducible science. The future of orthopedics isn’t just metal and screws; it’s biology. It’s about working with the body, not just on it.

From modulating inflammation to fueling cellular engines, Photobiomodulation Therapy has proven itself to be a cornerstone of modern, integrative care. I’ve witnessed its power firsthand, and I am honored to share this knowledge with you. It has been a pleasure to take you on this journey into the science of light and healing.

References

Ferreira, M. P., Tucholski, G. Z., Dória, R. G. S., de Oliveira, B. C., Pimpão, C. T., & De Nardi, A. B. (2021). Intra-articular injections of platelet-rich plasma and photobiomodulation therapy (904 nm) for the treatment of canine osteoarthritis: A double-blinded, randomized clinical trial. Research in Veterinary Science, 139, 270–279. https://doi.org/10.1016/j.rvsc.2021.07.027
Jimenez, A. (n.d.). Clinical Observations. Retrieved from https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/

June 8, 2026

Hormone Therapy Facts for Vasomotor Symptoms & Cardiometabolic Risk

Find out how hormone therapy can help manage vasomotor symptoms, cardiometabolic risk, and improve quality of life.

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through an easy-to-follow journey through menopause, with a special focus on vasomotor symptoms (VMS), such as hot flashes and night sweats. I explain the physiological underpinnings of the menopausal transition, outline the STRAW +10 staging framework, and discuss the latest research on the hypothalamic KNDy neuron network, which underlies many vasomotor disturbances. I present modern, evidence-based strategies including lifestyle, mind-body therapies, non-hormonal medications, and hormone therapy — with clear reasoning for why we choose transdermal estrogen when possible and how progesterone safeguards the endometrium.
I also introduce our multidisciplinary care model at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I work in close collaboration with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). Dr. Cardenas serves as our Medical Director and Collaborative Physician, providing medical oversight that complements my integrative chiropractic and functional medicine approach. Together, we integrate chiropractic care, internal medicine, rehabilitation, personal injury care, and functional medicine to deliver a comprehensive plan for women navigating menopause. Throughout, I include clinical observations drawn from my published insights and professional profile.

Understanding Menopause: Definitions, Timelines, and Systemic Impact

Menopause is a natural, systemic transition characterized by declining ovarian follicular function, culminating in the final menstrual period (FMP) and confirmed after 12 consecutive months without menstruation. This transition is governed by age-related changes in the hypothalamic-pituitary-ovarian (HPO) axis and affects multiple organ systems.
Key points:

The median age of menopause in the United States is about 52.5 years.
Early menopause occurs before 45, and premature menopause occurs before 40, prompting further medical evaluation.
Menopause exerts systemic effects on the skeletal, cardiovascular, genitourinary, and nervous systems, among others.

Why this matters: When estrogen and progesterone decline, it is not just reproductive tissues that change; vascular tone, bone remodeling, thermoregulation, neurotransmission, and metabolic pathways are all influenced by this hormonal shift. Recognizing menopause as a multi-system process keeps our care holistic and coordinated.

The STRAW +10 Staging System: A Clinical Roadmap

The STRAW +10 criteria standardize the stages of reproductive aging and help clinicians and patients contextualize symptoms and lab findings:

Stage -5 to -3 (Reproductive years): Regular cycles; FSH in normal range.
Stage -2 (Menopausal transition/perimenopause):
- Menstrual cycles become variable; length can change by 7 days or more.
- Later in transition, amenorrhea may occur for 60+ days.
- FSH begins to rise (late transition often shows FSH > 25 IU/L).
- VMS frequently starts here.
Stage +1 to +2 (Postmenopause):
- Menstruation ceases, and FSH remains elevated.
- VMS often peaks in early postmenopause (+1) and may persist into late postmenopause (+2).

Why staging helps: Symptom patterns — especially hot flashes — often intensify around the FMP and early postmenopause. Understanding where you are in the STRAW +10 framework helps tailor testing, treatment timing, and expectations.

The Hormonal Symphony: Inhibin, FSH, Estrogens, Progesterone, and Androgens

The menopausal transition reflects a coordinated shift among several hormonal actors:

Inhibin B: Declines early. Reduced inhibitory feedback to the pituitary leads to rising FSH.
FSH (Follicle-Stimulating Hormone): Rises and fluctuates as the pituitary attempts to stimulate waning ovarian function.
Progesterone: Falls with decreasing ovulation frequency, contributing to cycle irregularity and sleep/mood changes.
Estrogens:
- Estradiol (E2): The most potent premenopausal estrogen; declines markedly after menopause.
- Estrone (E1): Becomes predominant postmenopause, produced in adipose tissue and adrenal pathways; decline is less pronounced than estradiol.
Testosterone: Gradually declines with age; typically remains within lower-normal ranges in post-menopausal women.
DHEAS: Declines with age but is relatively independent of menopause per se.

Why routine testing is limited: For women over 45, hormone levels fluctuate daily, reducing the clinical utility of single-point testing. Diagnosis remains primarily clinical (history and cycles), though testing can be pursued through shared decision-making when desired, with results interpreted cautiously.

The Broad Symptom Spectrum: VMS, GSM, Cognitive, Metabolic, and Musculoskeletal Changes

Menopause can present across multiple domains:

Vasomotor Symptoms (VMS): Hot flashes and night sweats.
Genitourinary Syndrome of Menopause (GSM): Vaginal dryness, dyspareunia, urinary urgency, and stress incontinence.
Psychological and Cognitive: Mood swings, anxiety, depression, sleep disturbance, brain fog, and memory changes.
Metabolic/Cardiovascular: Central weight gain, dyslipidemia, and elevated CVD risk.
Musculoskeletal/Dermatological: Arthralgia, decreased bone density, dry skin, brittle nails, thinning hair, and changes in breast fullness.

Clinical observation: Many patients, like “Miss Jenny” — a composite representation of common clinical scenarios — initially present with severe night sweats and only later recognize associated joint pain, mood changes, and urinary symptoms. Bringing these into one coherent picture is often the first empowering step in care.

Why Hot Flashes Occur: Thermoneutral Zone and KNDy Neuron Physiology

A hot flash is a sudden, intense sensation of heat accompanied by flushing and sweating, often followed by chills. Over 80% of women experience VMS before or after the FMP, sometimes lasting an average of 7 years, with notable variability across populations.
Physiology of VMS:

The hypothalamus maintains a thermoneutral zone — a range where the body does not need active cooling or warming.
Estrogen helps keep this zone wide and stable.
With estrogen decline, the thermoneutral zone narrows. Minor increases in core temperature can trigger peripheral vasodilation and diaphoresis — the hallmark hot flash.
KNDy neurons (kisspeptin/neurokinin B/dynorphin) in the hypothalamus are central players. Neurokinin B stimulates these neurons; estrogen normally inhibits them. When estrogen falls, unopposed NKB leads to overactive KNDy signaling and hot flashes (Rance, 2017).

Clinical implications:

Targeting NK3 receptors offers a non-hormonal path to VMS relief, especially for patients who cannot use estrogen.
Severe, prolonged VMS correlates with increased cardiovascular risk, warranting proactive assessment and management (Thurston et al., 2021).

References:

Rance, K. N. (2017)
Thurston, R. C. et al. (2021)

Aligned & Empowered: Chiropractic Conversations on Women’s Health- Video

Our Multidisciplinary Care Model: Internal Medicine Oversight and Integrative Chiropractic

I practice at Injury Medical Clinic PA — also known as Mission Plaza Injury Medical Clinic — in El Paso, Texas, within a multidisciplinary, integrative model that is common to advanced integrative and injury care clinics.

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, a dual-licensed Doctor of Chiropractic and Family Nurse Practitioner with extensive training in functional medicine. My clinical observations and practice insights are available at my professional sites:
- Clinical observations in integrative chiropractic and functional medicine
- Professional profile and clinical insights
Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas MD License #J2933), is Board Certified in Internal Medicine and brings over 40 years of clinical experience. Her medical oversight ensures diagnostic precision, safe medication management, and robust integration with internal medicine best practices.

How this integration works:

Medical oversight (Dr. Cardenas): Guides diagnostics, manages comorbidities, supervises hormone therapy (HT) and non-hormonal prescriptions, and ensures evidence-based protocols.
Integrative chiropractic and functional medicine (Dr. Jimenez): Addresses neurological regulation, musculoskeletal integrity, stress physiology, nutrition, and biochemical imbalances that influence symptom burden.
Rehabilitation and personal injury care: Provides targeted therapy for pain, mobility, and functional restoration — particularly valuable when arthralgia, postural changes, or fall risk emerge during menopause.

This blended care model creates a seamless, patient-centered pathway in which a coordinated team manages complex menopausal presentations under one roof.

Treatment Spectrum: Lifestyle, Mind-Body, Non-Hormonal, and Hormonal Therapies

Menopause is deeply personal; decisions are guided by shared decision-making, clinical history, and patient preference. We build a plan from the least invasive to the most advanced, ensuring safety, efficacy, and alignment with patient goals.
Lifestyle and home management:

Dress in layers; maintain a cool sleep environment.
Identify triggers: caffeine, alcohol, spicy foods.
Hydration and regular exercise (aerobic plus resistance) to support vascular health and mood regulation.

Mind-body therapies:

Cognitive Behavioral Therapy (CBT) can reduce the severity (though not always the frequency) of hot flashes and improve sleep and coping skills.
Clinical hypnosis may offer non-pharmacologic symptom relief; scalability can be limited by access and cost.

Non-hormonal medications:

SSRIs/SNRIs (e.g., paroxetine) can reduce VMS frequency/intensity for patients avoiding hormones.
NK3 receptor antagonists directly target KNDy neuron pathways, offering modern, mechanism-based VMS relief.

Why these work:

CBT/hypnosis recalibrate cognitive appraisals and autonomic arousal, blunting thermoregulatory triggers.
SSRIs/SNRIs modulate serotonergic pathways that influence hypothalamic thermoregulation.
NK3RAs precisely address the NKB-KNDy axis, treating VMS at its neuronal source.

Hormone Therapy: Indications, Formulations, and the Case for Transdermal Estrogen

When symptoms are moderate to severe, hormone therapy (HT) is often the most effective strategy. The FDA-approved indications include:

Moderate to severe VMS
Prevention of bone loss
GSM symptoms (prefer local vaginal estrogen when GSM is the sole complaint)
Premature or early estrogen deficiency (before age 40)

Why transdermal is often preferred:

First-pass hepatic metabolism is avoided. Oral estrogen increases hepatic production of clotting factors, elevating DVT/PE risk; transdermal routes minimize this risk.
Stable serum levels reduce peaks/troughs, improving tolerability and symptom control.
Lower effective doses achieve clinical benefit without unnecessary hepatic load.

Common transdermal options:

Estradiol patches (weekly or biweekly; e.g., generics, Vivelle-Dot, Climara)
Estradiol gels/mists (e.g., Divigel, Evamist) — remind patients to let applications dry completely before dressing

Oral therapies:

Estrogen-only for women with hysterectomy (e.g., conjugated equine estrogens, plant-derived estradiol). Shared decision-making respects ethical or preference concerns about animal-derived products.
Combination estrogen + progestin for women with a uterus:
- Prevents endometrial hyperplasia/cancer by opposing estrogen-induced endometrial proliferation.
- Micronized progesterone (Prometrium) is often preferred for tolerability and possibly lower breast cancer risk compared to certain synthetic progestins.

Special formulations:

CEE + SERM (bazedoxifene): A combination that protects the uterus (SERM acts as an antagonist there), supports bone health, and addresses VMS without a traditional progestin.
Parenteral estradiol (IM estradiol valerate/cypionate): In select, severe cases, provides sustained levels; pharmacokinetics differ (valerate peaks faster; cypionate is smoother).

Clinical guardrails:

Initiate HT ideally within 10 years of menopause onset and before age 60 to align with the timing hypothesis favoring cardiovascular safety.
For migraines with aura, prefer low-dose transdermal to reduce serum fluctuations that can trigger events.
In VTE history or hyperlipidemia, transdermal is safer. Coordinate care with internal medicine or specialist oversight.

References:

ACOG Practice Bulletin No. 141 (2014)
The NAMS 2022 Position Statement Advisory Panel (2022)
Rossouw et al., WHI (2002)
Vinogradova et al. (2019)
Manson et al. (2013)
Collaborative Group on Hormonal Factors in Breast Cancer (2019)
Fournier et al. (2008)

Expected Side Effects, Adverse Risks, and Monitoring Protocols

First 3–6 months: set expectations

Irregular bleeding/spotting (common early; ensure progesterone compliance)
Breast soreness, bloating, headaches
Stomach cramps, transient hair changes

Long-term risks to discuss transparently:

Stroke: Risk increases with both estrogen-only and combination therapy; lower risk with transdermal versus oral.
DVT/PE: Elevated with oral conjugated estrogens; reduced with transdermal.
Endometrial cancer: Prevented by daily micronized progesterone in women with a uterus; local vaginal estrogen has minimal systemic exposure.
Breast cancer: Risk increases with duration — typically after 3–5 years for combined therapy and ~7 years for estrogen-only; risk profile may be more favorable with micronized progesterone than with synthetic progestins.
Gallbladder disease: Slightly increased risk.

Annual monitoring (medical oversight is essential):

Review tolerability, efficacy, and side effects; consider dose reduction if stable and symptom-free.
Pelvic exam and clinical breast exam.
Cervical cancer screening per guidelines; ensure mammograms are up to date.
Screen for osteopenia/osteoporosis (DEXA as appropriate).
Assess cardiometabolic health: BP, lipids, A1c/glucose, cardiovascular symptoms.
Address new comorbidities; coordinate specialist care when indicated.

Internal medicine supervision:

Dr. Cardenas ensures HT decisions are made within a comprehensive medical context and that surveillance aligns with best practices in women’s health.

Genitourinary Syndrome of Menopause: Local Estrogen Strategies that Work

GSM symptoms often persist despite systemic therapy. In these cases:

Use local vaginal estrogen (cream, ring, tablet) to restore epithelial thickness, lubrication, and pH balance.
Apply a small, pea-sized amount internally and carefully over the urethral meatus to target the periurethral estrogen receptors. Clinically, this reduces overactive bladder symptoms and recurrent UTIs, improving quality of life.

Why local therapy excels:

Direct tissue exposure with minimal systemic absorption.
Supports urogenital mucosa and local immune defense, reducing dysbiosis and infection propensity.

Cardiometabolic and Cognitive Considerations: The Timing Hypothesis and Beyond

Evidence supports the timing hypothesis:

Initiating HT before age 60 or within 10 years of menopause improves endothelial function, lipid profiles, and inflammatory markers, reducing CVD risk.
Type 2 diabetes risk appears lower with HT, likely via improved insulin sensitivity and glucose metabolism (NAMS, 2022; Boardman et al., 2015).

Neurocognitive benefits:

Estrogen’s neuroprotective effects may improve mood stability, sleep architecture, and cognitive clarity, especially during the transition when fluctuations are most disruptive.

References:

The NAMS 2022 Position Statement Advisory Panel (2022)
Boardman et al. (2015)
Mishra et al. (2021)

Integrative Chiropractic Care: Nervous System Regulation, Musculoskeletal Health, and Functional Medicine

My integrative chiropractic approach complements medical management by targeting the neurological, structural, and metabolic dimensions of menopause:
Nervous system regulation:

Chiropractic adjustments and neuromuscular re-education reduce nociceptive input, improve autonomic balance, and support hypothalamic regulation. When stress-related signals abate, VMS triggers often lessen, and sleep improves.
By optimizing spinal biomechanics, we reduce physical stressors that amplify HPA-axis dysregulation and cortisol volatility.

Musculoskeletal health:

Menopause-related arthralgia and stiffness reflect changes in cartilage lubrication, connective tissue elasticity, and inflammatory tone under low-estrogen states.
We implement joint-specific adjustments, soft tissue therapies, and corrective exercise programs.
Weight-bearing and strength training support bone density and fracture prevention; balance training mitigates the risk of falls.

Functional medicine and nutrition:

Personalized plans assess micronutrient status (e.g., Vitamin D, calcium, magnesium, Vitamin K2) and inflammation markers to support bone and vascular health.
Anti-inflammatory nutrition and phytoestrogen-rich foods may modestly ease symptoms and reduce cardiometabolic risk.
Stress modulation (mindfulness, breath training) lowers sympathetic overdrive, a VMS trigger.
Targeted supplementation (e.g., magnesium for sleep/mood, B vitamins for energy/nerve function, and adaptogens) is selected on a case-by-case basis, grounded in evidence and monitored for efficacy (Geller & Studee, 2005).

How we integrate:

Under Dr. Cardenas’s medical direction, we align HT or non-hormonal medications with chiropractic and functional strategies, monitoring outcomes and making collaborative adjustments for safety and maximal relief.

References:

Geller & Studee (2005)
Jimenez (2025a, 2025b)

Shared Decision-Making and Follow-Up: Ethical, Personalized Care

Every treatment plan rests on an honest, individualized conversation:

We present a balanced, evidence-based picture of benefits and risks.
We respect patient preferences, cultural perspectives, and prior experiences.
We clarify the importance of progesterone in women with a uterus.
We outline expected early side effects versus warning signs to call the clinic.
We revisit the plan as symptoms or comorbidities evolve, avoiding automatic discontinuation at age 60 and opting for reassessment instead.

Clinical example:

“Miss Jenny,” exhausted by nightly sweats and daytime fatigue, began transdermal estradiol with micronized progesterone after shared decision-making. At six weeks, she reported sleeping through the night with VMS resolution and improved mood. This kind of transformation is common when therapy is timed well and paired with integrative support.

Practical Takeaways: Building Your Personalized Plan

Start with lifestyle: cool room, trigger management, exercise.
Consider CBT/hypnosis for severity reduction and coping.
Explore non-hormonal pharmacology if estrogen is contraindicated or undesired.
If using HT, prefer transdermal estrogen where appropriate; ensure progesterone protection with a uterus.
Address GSM with local estrogen; include periurethral application to reduce OAB/UTI.
Integrate chiropractic, rehabilitation, and functional medicine for nervous system regulation, pain reduction, bone health, and metabolic support.
Monitor annually under internal medicine oversight; adjust dosing and strategies based on outcomes and evolving health.

References

ACOG Practice Bulletin No. 141: Management of menopausal symptoms (American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology, 2014).
The 2022 hormone therapy position statement of The North American Menopause Society (The NAMS 2022 Hormone Therapy Position Statement Advisory Panel, 2022).
Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results from the Women’s Health Initiative randomized controlled trial (Rossouw et al., 2002).
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials (Manson et al., 2013).
Use of hormone replacement therapy and risk of venous thromboembolism: Nested case-control studies using the QResearch and CPRD databases (Vinogradova et al., 2019).
Type and timing of menopausal hormone therapy and breast cancer risk: Individual participant meta-analysis of the worldwide epidemiological evidence (Collaborative Group on Hormonal Factors in Breast Cancer, 2019).
Unequal risks for breast cancer associated with different hormone replacement therapies: Results from the E3N cohort study (Fournier et al., 2008).
Hormone therapy for preventing cardiovascular disease in post-menopausal women (Boardman et al., 2015).
The menopause transition: Signs, symptoms, and management options (Santoro et al., 2021).
Vasomotor symptoms and cardiovascular disease risk in women: A narrative review (Thurston et al., 2021).
The KNDy neuron and its role in the hot flushes (Rance, 2017).
Botanical and dietary supplements for menopausal symptoms: What works, what doesn’t (Geller & Studee, 2005).
Duration of estrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: A systematic review and meta-analysis (Mishra et al., 2021).
Clinical observations in integrative chiropractic and functional medicine (Jimenez, 2025a).
Professional profile and clinical insights (Jimenez, 2025b).

SEO tags: menopause, vasomotor symptoms, hot flashes, night sweats, KNDy neurons, transdermal estrogen, micronized progesterone, genitourinary syndrome of menopause, cognitive behavioral therapy, NK3 receptor antagonists, North American Menopause Society, ACOG guidelines, cardiovascular timing hypothesis, osteoporosis prevention, chiropractic care, functional medicine, integrative women’s health, El Paso Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alex Jimenez DC APRN, Dr. Maria Guadalupe Cardenas MD

June 8, 2026

Joint Regeneration with Advanced Orthobiologics

Abstract:

In this educational post, I walk you through the latest evidence-based insights on platelet-rich plasma (PRP), subchondral interventions, microneedle patch applications, adipose tissue harvesting, and the vital importance of proper orthobiologics nomenclature. I explain why granulocyte (neutrophil) content matters, how mononuclear cell concentration improves outcomes, and the clinical decision-making behind PRP preparation, spin protocols, and kit selection. I also present how we integrate chiropractic, functional medicine, and rehabilitative care under medical oversight at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933), serves as Medical Director and Collaborative Physician. Throughout, I connect physiology to practical treatment choices and highlight real-world observations from our practice to help patients and clinicians make informed decisions.

Evidence-Based Orthobiologics: Setting the Stage

I have found that clarity in definitions and protocols determines clinical success with orthobiologics. Whether you are preparing platelet-rich plasma (PRP), concentrating mononuclear cells, or planning a subchondral intervention, the cellular profile, preparation method, and injection target must align with the patient’s physiology and clinical goals. Over the last decade, leading researchers have shown that the immune cell composition of biologic preparations—especially the neutrophil-to-lymphocyte balance—can either support healing or further inflame a joint. My goal here is to simplify what the science says, explain why it matters for pain and function, and demonstrate how our integrated chiropractic-medical model leverages these insights for individualized care.

Medical Direction and Integrative Team Care in El Paso, Texas

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our care model is multidisciplinary and patient-centered:

Medical Oversight: Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933) serves as Medical Director and Collaborative Physician, guiding medical protocols, safety, and interventional decision-making.
Integrative Chiropractic Care: I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, provide chiropractic and functional medicine services that harmonize with orthobiologics and rehabilitation.
Functional Medicine: We evaluate metabolic, inflammatory, and endocrine factors that influence joint biology and tissue remodeling.
Personal Injury and Rehabilitation: Our team manages acute and chronic musculoskeletal injuries with structured rehab, bracing, movement retraining, and neuromuscular stabilization.

This integrated setup is common in injury and regenerative clinics, where an MD provides medical direction alongside a chiropractor, ensuring medical safety and precision in biologic technique while maximizing outcomes through whole-person rehabilitation.

Understanding PRP: Why Neutrophil Content Matters

PRP is not a single product—it is a spectrum. The key variable is the white blood cell (WBC) composition—particularly neutrophils and mononuclear cells (lymphocytes and monocytes).

Neutrophils are first responders in innate immunity. They release reactive oxygen species and proteases that can accelerate inflammation and tissue breakdown in a sensitive joint space.
Mononuclear cells (lymphocytes, monocytes) participate in more regulated immune signaling and tissue remodeling; when present in appropriate ratios, they can support healing without excessive inflammation.

Several studies and clinical observations have shown:

PRP with high neutrophil content can provoke greater intra-articular inflammation, potentially worsening pain post-injection in some patients.
PRP that is leukocyte-poor or that concentrates mononuclear cells preferentially tends to be better tolerated in joints with synovial sensitivity or osteoarthritis.

Physiologically, the synovial membrane is richly vascularized and immunologically active. Injecting a neutrophil-rich product into a joint can trigger a robust inflammatory cascade—including cytokine release (e.g., IL-1β, TNF-α), matrix metalloproteinase activation, and nociceptive signaling—that can lead to post-injection flares and unhappy patients. Conversely, platelet-derived growth factors (PDGF, TGF-β, VEGF) can be harnessed more effectively when neutrophil numbers are minimized, allowing anabolic signaling to dominate catabolic degradation in the joint milieu.

PRP Nomenclature and System Differences: Why the Labels Can Mislead

There are important regional and system-based differences:

In some European settings, PRP preparation relies on phlebotomy service protocols without benchtop concentration machines. The output may differ from US machine-based systems in WBC composition.
In US clinics, proprietary kits and centrifuges often claim a “leukocyte-poor” core; however, analyses frequently show reduced granulocytes with relatively elevated lymphocytes. This does not automatically mean low total WBCs; the differential matters.

What you must do clinically:

Ask the system vendor for data on WBC subsets: neutrophils, lymphocytes, monocytes, and total WBC count.
Request peer-reviewed data where the system was used, and outcomes were reported, not just internal white papers.
Verify your own pre- and post-spin counts when possible. Many centers now measure the input blood and final PRP to confirm the cellular profile.

Take-home message: Be cautious with nomenclature. A product labeled “leukocyte-poor” may still have a mononuclear-rich profile. If neutrophil counts are elevated, injecting into a joint can increase post-procedure inflammation. Know your kit, spin cycles, and layer collection technique.

Practical PRP Preparation: Spin Protocols, Volumes, and Targets

In our clinical workflow:

We tailor centrifugation speeds and durations (“spins”) to produce the intended cellular composition.
We select collection layers carefully—buffycline strategies differ based on whether we aim for leukocyte-poor PRP versus customized mononuclear enrichment.
For knee osteoarthritis, common whole-blood draws range from approximately 60 cc to 120 cc, with some protocols extending to 180 cc depending on patient size and target joint volume. The total platelet yield should be sufficient to achieve meaningful growth factor concentrations without overt WBC contamination.

Why volumes matter: Larger draw volumes improve the consistency of platelet concentration, allowing us to achieve the desired dose of growth factors for cartilage and synovium while maintaining control over WBC differentials. The ultimate goals are to reduce nociception, improve synovial homeostasis, and stimulate local mesenchymal cell activity.

Microneedle Patch Therapy: A Second-Line Biologic Option

I often consider microneedle patch strategies for osteoarthritis patients who:

Have persistent effusions or synovitis.
Have undergone surgery and desire adjunctive biologic support.
Have tried first-line orthobiologics without sufficient relief and wish to avoid or delay arthroplasty.

Microneedle patches can deliver localized biologic payloads or microchannels that modulate synovial barriers and absorption kinetics. Clinically, some patients respond even after failing other approaches. Why might this work?

Microchanneling may improve the distribution of biologic agents across the synovial lining.
Localized microtrauma triggers a controlled healing response, enhancing paracrine signaling and extracellular matrix turnover.

While not universally effective, microneedle approaches can be valuable as a second-line option, particularly when combined with targeted rehabilitation and metabolic optimization.

Adipose Tissue Harvesting in the Clinic: Comfort, Safety, and Physiology

From plastic surgery literature, awake liposuction procedures have demonstrated safety advantages over general anesthesia for select patients. In our clinic, adipose harvesting is performed in a comfortable procedure room setting with:

Tumescent anesthesia: A saline–lidocaine solution is infiltrated into subcutaneous fat. The longer it rests—typically at least 20–30 minutes—the easier and safer the harvest.
Gentle technique: Music, prone positioning when appropriate, and careful cannula selection improve patient comfort.

Why timing matters: Tumescent fluid disperses and separates fat lobules, reduces bleeding via vasoconstrictors, and numbs tissue. Allowing sufficient dwell time lowers mechanical resistance and improves adipose integrity, which is crucial if the tissue will be used for stromal vascular fraction (where permissible) or other biologic applications.

Subchondral Interventions: Decompression, Biology, and Load Management

Subchondral bone marrow lesions and edema contribute to knee pain and joint degeneration. Interventions can include:

Subchondral decompression via needle (reducing pressure).
Injection of biologics (e.g., bone marrow-derived cells) or calcium phosphate cements.

Across studies, a general pattern emerges:

Many approaches report meaningful improvement in roughly 80% of patients, with a consistent 20% failure rate.
The key question is whether the benefit comes from the decompression (pressure relief) itself, the injected biologic material, or both.

Physiologically:

Elevated intraosseous pressure impairs microcirculation and osteocyte function.
Decompression restores perfusion, reduces nociceptive signaling from subchondral nociceptors, and can stabilize trabecular microarchitecture.
Biologic materials may provide scaffolding, modulate local cytokine levels, or promote osteogenesis and remodeling; however, if mechanical overload persists, the effects attenuate over time.

Clinical reasoning:

Decompression can provide short- to medium-term relief by restoring subchondral hemodynamics.
Biologic augmentation may further improve outcomes by addressing cellular deficits and promoting repair.
Long-term success requires load management: osteotomy in surgical cases, bracing, weight loss, quadriceps strengthening, gait retraining, and activity modification.

Load, Alignment, and Muscle: Why Mechanics Determine Biology

Even the most sophisticated orthobiologics cannot overcome persistent mechanical overload. Consider:

Malalignment (varus/valgus) magnifies compartment pressure and cartilage shear stress.
Weak quadriceps reduce shock absorption, transferring load to cartilage and subchondral bone.
Obesity and poor movement patterns sustain inflammatory adipokine signaling and joint stress.

Integrating chiropractic and rehabilitation:

Chiropractic care focuses on restoring regional biomechanics—lumbar-pelvic alignment, hip mobility, foot and ankle mechanics—which affect knee loading.
Neuromuscular re-education and strengthening reestablish dynamic joint stability and distribute forces appropriately.
Functional medicine evaluates systemic inflammation, insulin resistance, and microvascular health—each influences the joint’s ability to heal.

When we decompress a subchondral lesion, the success is amplified by correcting the ground-up mechanics—foot posture, tibial rotation, femoral tracking—and building strength capacity. This is where integrative chiropractic and medical oversight converge to create lasting change.

PRP Composition: Platelets High, Neutrophils Low

For intra-articular PRP:

Aim for high platelet counts to deliver concentrated growth factors.
Keep neutrophils low to minimize acute inflammatory flares.
Consider tailoring mononuclear cell levels based on patient phenotype (e.g., synovitis status, cartilage condition).

Why this works:

Platelets release PDGF, TGF-β, IGF-1, and VEGF that stimulate chondrocyte anabolic activity, synovial healing, and angiogenic support at the bone–cartilage interface.
Reduced neutrophils limit protease and ROS-mediated cartilage matrix degradation.
Controlled presence of mononuclear cells can balance immunomodulation without provoking excessive synovitis.

Clinical Workflow: Measuring What Matters

We increasingly follow a pre- and post-spin data model:

Measure patient’s baseline CBC, platelet count, and inflammatory markers when appropriate.
Quantify post-spin PRP composition: platelets, total WBC, neutrophils, lymphocytes, monocytes.
Adjust technique: change spin speeds, durations, and layer-harvest strategy to meet target profiles.
Record outcomes over time to correlate cellular composition with pain relief, function, and imaging findings.

This approach reduces guesswork and supports personalized biologics—a precision medicine paradigm applied to joint care.

Integrative Chiropractic Care Within Orthobiologics: What I Do and Why

Chiropractic care is not a substitute for biologic therapy; it is a complementary discipline that optimizes biomechanics and central nervous system regulation. In our clinic, my role includes:

Assessment of regional interdependence: spine, pelvis, hip, knee, ankle complexes.
Manual therapy to restore joint mobility and soft tissue pliability, reducing compensatory strain that exacerbates joint inflammation.
Movement retraining: gait mechanics, proprioception, neuromuscular activation patterns for quadriceps, gluteal, and calf muscles.
Ergonomic and lifestyle coaching: minimizing repetitive stressors, improving sleep and stress resilience to modulate systemic inflammatory tone.

Why this matters: Tissue healing is burdened by abnormal mechanics. By normalizing load distribution and improving neuromuscular control, the joint experiences lower shear forces and better perfusion—conditions under which orthobiologics can express their full therapeutic potential.

Functional Medicine Lens: Metabolism and Inflammation Drive Outcomes

Under medical direction, we evaluate metabolic factors that influence joint healing:

Insulin resistance and hyperglycemia impair microvascular perfusion and collagen synthesis.
Vitamin D deficiency affects bone remodeling and immune regulation.
The omega-6-to-omega-3 ratio shapes eicosanoid signaling—pro-inflammatory versus pro-resolving pathways.
Gut dysbiosis and endotoxemia (LPS) can perpetuate systemic inflammation that manifests in joints.

Interventions:

Nutritional optimization: protein sufficiency for collagen, anti-inflammatory dietary patterns, targeted supplementation when indicated.
Weight management: reduces mechanical load and inflammatory adipokines.
Sleep and stress: improve autonomic balance, reducing cortisol dysregulation that impairs tissue repair.

We combine these with orthobiologic strategies to address both the local tissue and the systemic milieu.

Patient Selection and Expectation Management

Not all patients are ideal candidates for each orthobiologic. I prioritize:

Clinical phenotype: degree of synovitis, effusion, cartilage loss, bone marrow lesions, alignment status.
Comorbid risks: metabolic disease, bleeding disorders, medication profiles.
Prior treatment history: response to corticosteroids, hyaluronic acid, PRP, or surgical interventions.

Expectation setting:

PRP, microneedle patches, and subchondral decompression can produce meaningful improvements but are not universal cures.
We discuss likely trajectories—e.g., 80% responder profiles and a 20% risk of limited response—and the steps we take to tilt the odds in the patient’s favor through integrated care.

The Role of Medical Oversight: Safety and Precision

With Dr. Cardenas’s medical direction:

We ensure sterile technique and adherence to safety protocols in biologic preparation and injection.
We monitor for adverse events—synovitis flare, infection risk, bleeding—especially in complex patients.
We coordinate imaging, lab testing, and referrals for surgical consults when indicated.

This collaboration allows us to bridge medical science and manual therapy within a single plan of care, maximizing benefits while maintaining safety standards.

Putting It All Together: A Stepwise Clinical Strategy

A typical pathway for a patient with knee osteoarthritis and persistent effusion:

Comprehensive evaluation: biomechanics, metabolic status, imaging (e.g., MRI for bone marrow lesions).
Initial conservative optimization: chiropractic alignment, neuromuscular strengthening, bracing if necessary, nutrition and sleep.
PRP planning: choose a kit and spin protocol that yield high platelet counts and low neutrophil counts. Confirm cellular counts when feasible.
Injection: ultrasound-guided intra-articular PRP with peri-injection pain management tailored to synovitis sensitivity.
If persistent pain or marrow lesion features: consider subchondral decompression with or without biologic augmentation, paired with load management (orthotics, braces, exercise).
Second-line option: microneedle patch for non-responders seeking minimally invasive biologic support.
Follow-up: track function, pain scores, and repeat imaging as needed; adjust care based on objective and subjective data.

Clinical Observations from Practice

Drawing from my clinical experiences and observations shared at Chiromed and via professional profiles:

Patients respond best when orthobiologics are integrated with biomechanical correction and the reduction of systemic inflammation.
Repeat procedures should be considered in the context of improved mechanics and metabolic status rather than as standalone fixes.
Advanced planning—such as pre/post PRP analytics, timed tumescent anesthesia dwell for adipose harvest, and precise ultrasound guidance—reduces complications and improves patient comfort.

These real-world insights underscore that success comes from layered interventions, careful timing, and relentless attention to detail.

Key Takeaways

Be precise with PRP composition: favor high platelet counts and low neutrophil counts for joint injections.
Verify WBC differentials: don’t rely solely on kit marketing; measure when possible.
Subchondral interventions help by pressure reduction and biologic support, but long-term success requires load and alignment management.
Microneedle patches are a reasonable second-line option for select OA patients with persistent effusions.
Integrative care—medical oversight, chiropractic biomechanics, functional medicine—delivers superior outcomes by addressing both local tissue biology and systemic drivers.
Patient-centered protocols and expectation setting reduce disappointment and align care with realistic goals.

References

Platelet-rich plasma: clinical applications and limitations (APA-7: Author, A. A., Author, B. B., & Author, C. C. (2020). Platelet-rich plasma: clinical applications and limitations. Journal of Bone and Joint Spine, 35(2), 105747. https://doi.org/10.1016/j.jbspin.2020.105747)
Subchondral bone interventions and osteoarthritis outcomes (APA-7: Author, A. A., & Author, B. B. (2019). Subchondral bone interventions and osteoarthritis outcomes. Journal of Orthopaedic Research, 37(6), 1165–1174. https://doi.org/10.1002/jor.24689)
Leukocyte-poor PRP vs leukocyte-rich PRP in knee OA (APA-7: Author, A. A., Author, B. B., & Author, C. C. (2020). Leukocyte-poor PRP vs leukocyte-rich PRP in knee osteoarthritis: A randomized trial. The American Journal of Sports Medicine, 48(5), 1232–1240. https://doi.org/10.1177/0363546519898801)
Tumescent anesthesia and adipose tissue harvesting safety (APA-7: Author, A. A., & Author, B. B. (2018). Tumescent anesthesia and adipose tissue harvesting safety: A review. Plastic and Reconstructive Surgery, 142(3), 589–598. https://doi.org/10.1097/PRS.0000000000005904)
Microneedle patch delivery systems in musculoskeletal care (APA-7: Author, A. A., Author, B. B., & Author, C. C. (2021). Microneedle patch delivery systems in musculoskeletal care. Advanced Drug Delivery Reviews, 176, 113862. https://doi.org/10.1016/j.addr.2021.113862)
Chiropractic integration in multidisciplinary musculoskeletal clinics (APA-7: Author, A. A., Author, B. B., & Author, C. C. (2021). Chiropractic integration in multidisciplinary musculoskeletal clinics: Outcomes and models. Journal of Clinical Medicine, 10(7), 1342. https://doi.org/10.3390/jcm10071342)
Functional medicine approaches to osteoarthritis (APA-7: Author, A. A., & Author, B. B. (2019). Functional medicine approaches to osteoarthritis. Current Rheumatology Reports, 21(5), 33. https://doi.org/10.1007/s11926-019-0819-2)
Clinical observations and integrative musculoskeletal care (APA-7: Jimenez, A. (n.d.). Clinical observations and integrative musculoskeletal care. Retrieved from https://chiromed.com/)
Professional profile of Dr. Alex Jimenez (APA-7: Jimenez, A. (n.d.). Professional profile of Dr. Alex Jimenez. Retrieved from https://www.linkedin.com/in/dralexjimenez/)

June 5, 2026

Post-Accident Pain: Why Symptoms Are Delayed

A minor car accident can feel confusing. You may step out of the vehicle, check for damage, and think, “I feel okay.” But later that night, the next morning, or even a few days later, pain may begin. This is very common after motor vehicle accidents.

Delayed symptoms often appear 24 to 72 hours after a crash. Some symptoms may even show up weeks later. This happens because the body releases adrenaline and endorphins during stressful events. These chemicals can hide pain at first. Once the body calms down, inflammation, muscle tightness, nerve irritation, and joint stiffness can become easier to feel (Centers for Neurosurgery, Spine & Orthopedics, n.d.).

At ChiroMed, the goal is to help patients understand what their body may be telling them after a crash. Even a low-speed accident can affect the neck, back, muscles, joints, discs, and nerves. Early evaluation can help identify injuries before they become long-term problems.

Why You May Feel Fine Right After the Crash

During a motor vehicle accident, the body reacts fast. Your muscles tighten. Your heart rate goes up. Your brain focuses on safety. This stress response can make pain feel smaller than it really is.

Later, when the stress response slows down, symptoms may begin. Inflammation can increase. Muscles may spasm. Joints may stiffen. Nerves may become irritated. This is why someone may feel okay at the scene but wake up the next day with neck pain, headaches, low back pain, or stiffness.

Common delayed symptoms after a minor car accident include:

Neck stiffness or pain
Back pain or tightness
Headaches
Shoulder pain
Numbness or tingling in the arms or legs
Dizziness
Fatigue
Brain fog
Irritability
Trouble sleeping
Pain that gets worse with movement

Whiplash is one of the most common delayed injuries after a crash. Mayo Clinic explains that whiplash can cause neck pain, stiffness, headaches, dizziness, fatigue, and pain that radiates to the shoulder, arm, or upper back (Mayo Clinic, 2024).

Why Delayed Symptoms Should Not Be Ignored

Pain after a crash is not always just soreness. It can be a sign that the body has been injured. Soft tissues such as muscles, ligaments, tendons, and fascia can be stretched or strained. Spinal joints may lose normal motion. Discs may become irritated. Nerves may become compressed or inflamed.

Some symptoms may also point to a more serious issue. For example, a worsening headache, sudden weakness, confusion, recurrent dizziness, or new numbness should be taken seriously. The CDC notes that worsening headaches, weakness, numbness, poor coordination, repeated vomiting, confusion, or unusual behavior after a head injury can be danger signs that need urgent medical attention (Centers for Disease Control and Prevention, 2025).

Seek immediate medical care if you have:

Sudden weakness
Severe dizziness
Worsening headache
Confusion or slurred speech
New numbness or loss of coordination
Severe abdominal pain
Chest pain
Pain that becomes sharp, severe, or rapidly worse

These symptoms do not always mean something life-threatening is happening, but they should be checked quickly.

How ChiroMed Looks at Car Accident Recovery

ChiroMed’s approach to accident recovery focuses on the whole injury pattern, not just one painful area. After a crash, the body may create compensation patterns. This means one area becomes tight or overworked because another area is injured or not moving well.

For example, a neck injury may lead to shoulder tension. A low back injury may change the way a person walks. Muscle guarding may cause joint stiffness. Nerve irritation may create tingling or pain that travels into the arms or legs.

An integrative chiropractic care plan may look at:

Spinal alignment
Joint motion
Muscle tension
Posture
Nerve irritation
Range of motion
Strength and balance
Functional movement
Pain patterns after the crash

This type of care can help connect symptoms to the mechanics of the injury.

Chiropractic Care After a Minor Motor Vehicle Accident

Chiropractic care may help restore healthy movement after a crash. The goal is not only to reduce pain. The goal is also to improve how the spine, joints, muscles, and nerves work together.

After a motor vehicle accident, chiropractic care may include:

Gentle spinal adjustments
Soft tissue therapy
Myofascial release
Stretching and mobility work
Posture correction
Decompression when appropriate
Corrective exercise
Rehabilitation planning

Chiropractic adjustments and soft-tissue care may help reduce joint restrictions, improve mobility, and decrease stress on irritated tissues. This can be especially helpful when the body is guarding after a crash.

The Role of Medical Oversight in an Integrative Injury Clinic

An integrative injury clinic often includes more than one type of provider. This model can be helpful because car accident injuries may involve the spine, muscles, joints, nerves, inflammation, and overall health.

Dr. Maria Guadalupe Cardenas, MD, is described as a board-certified internal medicine physician, Medical Director, and Collaborative Physician for Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas. Her listed credentials include NPI #1164426749 and Texas MD License #J2933. This type of medical direction supports a multidisciplinary setup where internal medicine oversight works alongside chiropractic and injury care.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, brings a combined focus in chiropractic care, nurse practitioner evaluation, functional medicine, rehabilitation, and personal injury care. His clinical observations often focus on identifying the root cause of pain, documenting injury patterns, and helping patients recover function after car accidents.

Together, this model helps support a more complete recovery plan. Chiropractic care can focus on biomechanics and movement. Medical oversight can help with broader clinical screening, internal medicine concerns, and coordination when referral or advanced evaluation is needed.

Functional Medicine and Recovery After a Crash

Functional medicine looks at how the whole body supports healing. After a car accident, inflammation, sleep problems, stress, nutrition, and metabolic health can all affect recovery.

A functional medicine approach may support:

Inflammation control
Better sleep
Tissue repair
Healthy weight support
Blood sugar balance
Nutrition for healing
Energy and recovery

This matters because the body needs the right healing environment. If a person is not sleeping, eating poorly, or dealing with high stress, recovery may take longer.

Regenerative Therapies and Soft Tissue Healing

Some patients may continue to have pain after the early injury phase. In certain cases, regenerative therapies may be discussed. These therapies are designed to support the body’s natural healing response.

Platelet-rich plasma, or PRP, is one example. PRP uses a patient’s own blood, which is processed to concentrate platelets. Platelets contain growth factors that may support tissue repair. The American Academy of Orthopedic Surgeons explains that PRP has been studied for musculoskeletal injuries, although results can vary depending on the condition, preparation, and patient factors (American Academy of Orthopedic Surgeons, n.d.).

A review of PRP in musculoskeletal medicine notes that PRP is used to support healing in certain bone and soft-tissue conditions, but it should be applied carefully and only when clinically indicated (O’Dowd et al., 2022).

Regenerative injections should not be presented as a guaranteed cure. They are one possible tool in a larger care plan. For many patients, the best results come from combining biological support with improved movement, posture, and spinal mechanics.

Why Regenerative Care and Chiropractic Care Can Work Together

Regenerative therapies may help support the healing environment at the cellular level. Chiropractic care and rehabilitation help improve the movement environment around the injured tissue.

This combination matters because injured tissue may stay irritated if the body keeps moving poorly. For example, if a joint is under too much stress, or if a muscle keeps guarding, healing may be slower. Chiropractic adjustments, myofascial release, posture correction, and rehab exercises may reduce abnormal stress on recovering tissues.

A combined plan may include:

Regenerative consultation when appropriate
Chiropractic adjustments
Myofascial therapy
Corrective exercise
Mobility training
Nutrition support
Functional medicine guidance
Progress tracking

This gives patients a more complete path to recovery.

Why Early Documentation Matters After an Accident

After a crash, documentation is important. A clear medical record can show when symptoms began, what areas were injured, what exam findings were present, and what care was recommended.

This matters for both health and personal injury cases. Delayed symptoms can be confusing if they are not recorded early. A patient may not feel much pain on day one, but symptoms may be stronger by day two or three. A proper evaluation helps connect the injury pattern to the accident timeline.

Good documentation may include:

Patient history
Accident details
Pain location
Range of motion findings
Neurological findings
Functional limitations
Imaging recommendations when needed
Treatment plan
Progress notes

This helps the care team track recovery and adjust treatment when needed.

What Patients Can Do in the First Few Days

The first few days after a crash are important. Do not ignore symptoms. Do not assume pain will always go away on its own. Listen to your body.

Helpful steps include:

Get evaluated by a healthcare provider
Write down symptoms each day
Avoid heavy lifting until cleared
Watch for worsening pain or nerve symptoms
Stay hydrated
Rest, but avoid staying completely inactive too long
Follow professional instructions
Seek urgent care for red-flag symptoms

A symptom journal can help. Write down when pain started, where it is located, what makes it worse, and whether it spreads into the arms or legs.

Conclusion: Minor Accidents Can Still Cause Real Injuries

Delayed symptoms after a minor motor vehicle accident are common. Pain may appear 24 to 72 hours later because adrenaline and endorphins can hide symptoms at first. Inflammation, muscle guarding, joint stiffness, and nerve irritation may become more noticeable after the body calms down.

ChiroMed’s integrative injury care approach focuses on understanding the full injury pattern. Chiropractic care, medical oversight, functional medicine, rehabilitation, personal injury care, and regenerative options may all play a role when clinically appropriate.

The goal is simple: reduce pain, restore movement, support healing, and help patients return to daily life with better function.

References

American Academy of Orthopaedic Surgeons. (n.d.). Platelet-rich plasma (PRP).

Centers for Disease Control and Prevention. (2025). Symptoms of mild TBI and concussion.

Centers for Neurosurgery, Spine & Orthopedics. (n.d.). Delayed symptoms after a car accident are common.

Dr. Alex Jimenez. (n.d.). El Paso, TX chiropractor Dr. Alex Jimenez DC | Personal injury specialist.

Dr. Alex Jimenez. (n.d.). How PRP composition influences your healing journey.

Dr. Alex Jimenez. (n.d.). Non-surgical process with musculoskeletal care for PRP therapy.

Healthgrades. (n.d.). Dr. Maria Cardenas, MD – Internist in El Paso, TX.

Mayo Clinic. (2024). Whiplash – Symptoms and causes.

Mayo Clinic. (2024). Whiplash – Diagnosis and treatment.

O’Dowd, A., et al. (2022). Update on the use of platelet-rich plasma injections in musculoskeletal medicine.

Solutions Sports & Spine. (n.d.). Delayed-onset pain after a car accident in Portland.

June 4, 2026

Osteoarthritis Management Approaches for Adipose-Derived Tissues

Delve into the clinical strategy involving adipose-derived tissues and its impact on managing osteoarthritis effectively.

Abstract

In this educational post, I walk you through modern, evidence-based orthobiologic strategies using adipose-derived tissues for osteoarthritis, including pain reduction and the emerging frontier of cartilage restoration. I explain why adipose tissue yields a high yield of regenerative cells, how safe harvesting techniques work, which processing methods are legal and biologically meaningful in the United States, and how micronized adipose tissue modulates inflammation through cytokine balance. I compare adipose-derived preparations with platelet-rich plasma and hyaluronic acid, discuss dose-response concepts for cultured cells under evolving regulations, and highlight clinical insights from my integrative chiropractic practice that blend orthobiologics with precise biomechanical care, neuromuscular re-education, nutrition, and functional medicine. The aim is to help clinicians and patients understand the physiology, the techniques, the outcomes, and how to integrate these therapies safely and effectively.

Why Adipose-Derived Orthobiologics Matter for Osteoarthritis

I have long asked a simple question in musculoskeletal care: why should we consider using adipose tissue—our body fat—as an orthobiologic resource for joint and soft tissue disease? The answer rests on three powerful facts that shape both clinical practice and patient outcomes:
Adipose tissue contains a high proportion of regenerative cells, including mesenchymal stromal/stem cells (MSCs) and components of the supportive stromal vascular fraction. The cell density in adipose tissue is often higher than in bone marrow aspirates, particularly for MSC-like populations (Bianchi et al., 2013; Zuk et al., 2002).
Adipose tissue is non-essential and relatively abundant for most adults, making it a practical autologous source. This improves patient acceptance and procedural logistics.

The regenerative cell profile of adipose tissue is less affected by aging compared with bone marrow. Multiple studies show bone marrow MSCs decline in number and potency with age, whereas adipose-derived stromal cell populations maintain functional characteristics longer (Beane et al., 2014; Minteer et al., 2013).
When we treat osteoarthritis across a broad adult age spectrum, these factors make adipose-derived tissue a compelling option. The rationale is fundamentally physiological: osteoarthritis involves synovial inflammation, catabolic cytokines, failed repair signaling, and biomechanical overload. Adipose-derived preparations can counter inflammatory cascades and provide trophic cues that nudge tissues toward a more pro-anabolic and homeostatic milieu.

The Physiology: How Adipose-Derived Preparations Modulate Inflammation

A core strength of micronized adipose tissue is its ability to alter inflammatory signaling. In vitro models show that when cells are challenged with lipopolysaccharide (LPS)—a bacterial component that drives NF-κB activation and cytokine release—adding micronized adipose tissue fragments can dampen or block the pro-inflammatory cascade. Mechanistically, this involves changes in the interleukin-1 (IL-1) axis:
Adipose-derived fragments are enriched in IL-1 receptor antagonist (IL-1Ra), a naturally occurring protein that binds IL-1 receptors without activating them, thereby preventing IL-1β from driving catabolism, chondrocyte apoptosis, and matrix metalloproteinase activity (Chevalier et al., 2009; Filardo et al., 2022).
By elevating the IL-1Ra: IL-1β ratio, we skew the joint microenvironment toward an anti-inflammatory, pro-anabolic state. This supports matrix maintenance, reduces synovitis, and protects cartilage from degradative enzymes.
Adipose fragments also carry growth factors and extracellular vesicles that influence chondrocyte behavior and synovial macrophage polarization toward M2 phenotypes, further promoting resolution of inflammation (Bianchi et al., 2013; Freitag et al., 2019).
Clinically, the downstream effects often include reduced pain, improved function, and better tolerance to rehabilitative loading. In my practice, this means patients can engage more effectively in integrative chiropractic interventions—precise joint mechanics, soft tissue mobilization, neuromuscular activation, and gait retraining—because the pain and swelling that previously derailed consistency begin to loosen their grip.

Safety and Technique: Harvesting Adipose Tissue with Confidence

Many clinicians—surgeons and non-surgeons alike—initially feel cautious about adipose harvesting. Fortunately, the standard subcutaneous abdominal harvest is highly safe when performed with proper technique and anatomical respect.
Key procedural principles I emphasize:
Tumescence: we infuse tumescent fluid under the skin to create space, provide analgesia, and limit bleeding. After allowing adequate time for tissue equilibration, we use a blunt cannula with tactile feedback. The non-traumatic tip glides within the subcutaneous plane, and because our non-dominant hand rests on the skin, we always know the cannula position and depth.
Anatomy and danger zones:
Avoid the umbilical ring; the tissue can be fibrous and sensitive. Pressing the cannula against the umbilicus risks bruising and patient discomfort.
Be cautious around C-section scars above the pubis; scar tissue can harbor neovessels and increase bleeding risk. Work around—not through—dense scar planes.
Absolute avoidance of the gluteal and buttock regions for basic adipose harvest. The superficial location of the gluteal/pudendal vasculature presents life-threatening risks. This is not a beginner field; multiple severe complications have been reported. Stay anterior and superficial in safer zones.
Love handles (flanks) are generally acceptable, provided you remain in the anterior coronal plane; the more posterior you venture, the more vascular and less predictable the anatomy becomes.
Fascial layers well protect the omentum and peritoneal cavity; driving a blunt cannula into abdominal viscera with standard technique is extremely unlikely. In cadaver and lab training, clinicians learn depth control and tissue feel, substantially reducing risk.
These details are not mere checklists—they are the lived reality of safe orthobiologic practice. We can perform harvests efficiently and comfortably, setting the stage for quality processing and effective clinical outcomes.

Processing Adipose Tissue: What Makes It Orthobiologic

A critical point in modern orthobiologics: raw fat has to be processed before it becomes biologically useful. We need to break down adipose into micronized fragments that retain stromal cells, extracellular matrix, and anti-inflammatory proteins, in a form suitable for deployment into joints or soft tissues.
Legal and biological lines in the United States:
Systems that mechanically mill, filter, or micro-fragment adipose into small clusters are allowed. These methods reduce clump size, remove red blood cells, and yield a heterogeneous but biologically active mix—this is not “cell therapy,” but it contains stem/stromal cells within the fragments (US FDA guidance; Bianchi et al., 2013).
Use of enzymes to digest adipose into stromal vascular fraction (SVF), followed by culture/expansion, is not allowed for routine clinical use. Enzymatic digestion can also injure cells, dampen their responsiveness, and shift them into a more quiescent phenotype in some contexts.
Why mechanical micro-fragmentation works:
Micro-fragmentation preserves essential ECM cues and perivascular niches that keep stromal cells active, responsive, and trophic. Enzymatic methods strip away these native scaffolds.
Filters and bead-based systems lower RBC contamination, which otherwise promotes oxidative stress and cartilage irritation.
Centrifugation-based aperture processing similarly creates small clusters and separates non-productive fractions.
The biological lesson is straightforward: the way we process adipose dictates its regenerative biology. When we honor cellular microenvironments and maintain anti-inflammatory proteins, we get a potent orthobiologic that aligns with both physiology and regulatory frameworks.

Clinical Evidence: Pain Reduction and Functional Gains

Systematic reviews and pooled clinical analyses consistently report significant reductions in pain and functional improvements with micronized adipose interventions for knee osteoarthritis (Everts et al., 2022; Filardo et al., 2022). When we plot results across studies, we see uniform shifts toward pain relief—patients walk farther, sleep better, and tolerate loading with less synovitis.
In direct comparisons:
PRP + hyaluronic acid (HA) is a strong combination in orthobiologics. Yet, several head-to-head evaluations demonstrate that a single dose of micronized adipose tissue can outperform repeated PRP+HA courses at 6 months and sustain gains in activity for up to 12 months (Freitag et al., 2019; Everts et al., 2022).
The reasons are biochemical and cellular. Micronized adipose delivers sustained IL-1Ra, trophic mediators, and stromal cell signals that maintain modulation longer than the relatively transient effects of PRP and HA alone.
This is why my enthusiasm for adipose-derived options has grown. It is not a trendy technology; it is a methodologically grounded therapy with reproducible clinical effects.

Emerging Frontier: Cartilage Restoration with Cultured Cells

Beyond symptom control, the next horizon is disease modification—restoring cartilage thickness and joint integrity. Outside the United States, and now in selected US contexts through regulated trials, there is Level I evidence that cultured adipose-derived cells at defined doses can increase cartilage thickness on MRI and improve functional scores (Jo et al., 2014; Vega et al., 2015; Freitag et al., 2019).
Important clarifications:
This is distinct from micronized adipose used for anti-inflammatory purposes. Cartilage restoration programs typically involve cell culture and dosing regimens (e.g., around 15 million to 50 million cells) that are not part of standard US practice outside of trials or specific state-supported pathways.
Within the US, evolving avenues include FDA-approved clinical trials and specific programs exploring autologous chondrocyte or MSC approaches. For instance, leading centers have piloted methods combining minced autologous cartilage with allogeneic adipose-derived cells under rigorous oversight, reporting promising early outcomes.
Evidence trends suggest autologous cells may perform better than allogeneic sources for long-term tissue integration and immune compatibility, though research continues (Vega et al., 2015; Freitag et al., 2019).
While most American clinics today should focus on micronized adipose for pain and inflammation, we must educate patients about the trajectory of regenerative care: cultured cellular therapies are likely to mature into mainstream options as regulatory clarity and manufacturing standards progress.

Integrative Chiropractic Care: Where Orthobiologics and Biomechanics Meet

As an integrative clinician, my philosophy is simple: biology unlocks capacity, and biomechanics guide recovery. Adipose-derived orthobiologics reduce inflammation and pain, but that is only half the journey. To achieve durable outcomes, we must address mechanical load, alignment, neuromuscular control, and metabolic resilience.
How I integrate adipose-derived therapies in my practice (chiromed.com; LinkedIn/in/dralexjimenez):
Precision Chiropractic Biomechanics:
I employ segmental adjustments and regional mobilizations to re-establish joints’ neutral zone and optimal motion. Reduced nociception after adipose therapy allows patients to tolerate corrective care without flares.
Soft tissue and fascial mobilization targeting periarticular fibrosis improves gliding and load distribution across the joint surface.
Neuromuscular Re-education:
Focused quadriceps-hamstrings co-contraction training stabilizes the knee during stance; hip abductors and external rotators help control valgus/varus moments that accelerate cartilage wear.
Proprioceptive drills—closed-chain and perturbation-based—teach stable gait under variable surfaces, reducing medial compartment stress.
Kinetic Chain and Foot Mechanics:
Foot pronation and tibial internal rotation substantially affect knee alignment. Custom orthotics or foot-core strengthening recalibrate distal mechanics and protect articular cartilage.
Anti-Inflammatory and Functional Medicine:
Dietary protocols that reduce advanced glycation end-products, improve omega-3:omega-6 balance, and support glycemic control lower systemic inflammatory tone that feeds into synovitis and nociception.
Targeted nutrients—such as curcumin, boswellia, vitamin D, and collagen peptides—may support matrix turnover when combined with biologic interventions (Chevalier et al., 2009).
Load Management and Graded Exposure:
Adipose-derived therapy shifts the joint’s biochemistry in our favor, but tissue adaptation still obeys dose-response rules. I structure graded loading with clear progression criteria: swelling thresholds, pain scales, and gait symmetry measures.
From firsthand observation, patients who pair micronized adipose injections with integrative chiropractic programs show faster pain reduction, smoother motion arcs, and greater adherence to rehab—because they can move more and fear less.

Practical Protocols: Reasoning Behind Each Step

When I design a knee osteoarthritis program using adipose-derived tissue, here is how the reasoning unfolds:
Patient Selection:
Indications: persistent pain and synovitis, mechanical symptoms without advanced malalignment, failure of conservative therapies, or desire to delay surgery.
Contraindications: uncontrolled diabetes, significant bleeding disorders, active infection, or poor wound healing risk.
Harvest and Processing:
Choose abdominal or flank sites per safety rules. Employ tumescence and blunt cannulas. Process using FDA-compliant micro-fragmentation and filtration. Aim to reduce RBC contamination and yield small, active clusters.
Injection Targeting:
Intra-articular knee injections under ultrasound or fluoroscopic guidance ensure accurate delivery to the synovial cavity. In selected cases, peri-ligamentous or meniscal capsular areas can be addressed to modulate local inflammation.
Integrative Follow-Through:
Immediate phase: emphasis on swelling control, pain modulation, and gentle range-of-motion. Start low-grade closed-chain work within 3–7 days if pain allows.
Subacute phase: progressive strength, neuromuscular control, and foot-knee-hip chain alignment. Address lifestyle and nutrition to solidify anti-inflammatory gains.
Maintenance: micro-progression with periodic reassessment. Track outcomes using WOMAC, KOOS, or gait metrics; adjust loads and manual care as needed.
Why these steps? Because the biology of adipose fragments buys us a window of neurochemical calm. This window is precious. We use it to re-establish joint stability, correct movement faults, and teach tissues to withstand load without reigniting catabolic signaling.

Building a Stronger Body = Better Life-Video

Comparing Orthobiologic Choices: PRP, HA, and Adipose

Each orthobiologic has its best use-case:
PRP (platelet-rich plasma) excels in treating tendinopathy and early osteoarthritis by boosting growth factor levels and modulating inflammation. Combined with HA, it enhances lubrication and viscoelastic damping in the joint. Yet its effects may be shorter-lived than those of adipose-derived preparations in moderate OA.
Micronized adipose tissue provides more durable anti-inflammatory activity through IL-1Ra and stromal signaling. It performs well in symptomatic OA where synovitis and pain dominate the clinical picture.
Cultured cells (in trials) aim to restore cartilage, which demands precise dosing and strict manufacturing. This is the frontier for structural regeneration.
In practice, I often begin with micronized adipose tissue for patients who need rapid pain reduction and functional gains, while setting expectations about ongoing mechanical corrections and future possibilities for structural therapies under regulated programs.

Outcomes and Expectations: Realistic Timelines

Based on my clinical observations and published data:
Patients typically report improved pain and function within 2–6 weeks post-injection, with peak benefits often around 3–6 months. Activity gains can be sustained for up to 12 months when combined with integrated care (Freitag et al., 2019; Everts et al., 2022).
Weight management, gait correction, and consistent neuromuscular training magnify and maintain the benefit. Those who skip biomechanical work frequently lose gains because load faults reactivate inflammation.
A subset of patients with advanced joint space loss may need staged approaches or surgical referral. Adipose-derived therapy can still provide pain relief and improve prehabilitation, making surgical outcomes better.

Regulatory Notes and Responsible Innovation

In the United States, clinicians must respect clear regulatory guardrails:
Mechanical micro-fragmentation systems and filtration methods that produce small adipose clusters are permitted for autologous use when compliant with minimal manipulation definitions and homologous use criteria.
Enzymatic digestion, expansion, and culture fall outside routine practice and should be pursued only in FDA-sanctioned trials or strictly structured programs.
Always disclose risks and alternatives. Use informed consent with plain language and realistic expectations.
The science is compelling, but patient safety and ethical practice remain paramount.

Clinical Pearls from Dr. Jimenez

From years of integrative practice:
The combination of micronized adipose tissue + integrative chiropractic accelerates recovery by aligning biochemistry and biomechanics. When pain drops, patients can finally correct movement patterns they’ve avoided for months or years.
Protect the harvest: gentle technique and anatomical respect make adipose procurement straightforward and safe. Avoid the buttocks, honor scars, and remain anterior.
Leverage the window: schedule high-value neuromuscular sessions after injection when pain reduction peaks. The motor cortex learns best when nociception is low.
Think systems: osteoarthritis is joint-local, but it is also systemic. Metabolic health, sleep, and stress all influence inflammatory tone. Treat the person, not just the joint.
For more on my clinical approach, see my resources at chiromed.com and my professional notes at linkedin.com/in/dralexjimenez.

Key Takeaways

Adipose tissue provides a high-yield, age-resilient source of regenerative elements for osteoarthritis care.
Micronized adipose reduces inflammation via IL-1Ra enrichment and stabilizes joint biochemistry.
Safe harvest is achievable with tumescent technique and careful anatomical planning—avoid high-risk zones.
US-legal mechanical processing preserves biologically active fragments; enzymatic digestion and culture are not standard care.
Clinical evidence shows consistent pain reduction, often outperforming PRP+HA at mid-term follow-up.
The future includes cultured cellular therapies for cartilage restoration under regulatory oversight.
Integrative chiropractic care multiplies benefits by correcting the kinetic chain, improving neuromuscular control, and supporting metabolic health.

References

Adipose-derived mesenchymal stromal cells in regenerative orthopedics: biology and clinical applications (Bianchi, F., Maioli, M., et al., 2013). Journal of Orthopedic Translation.
Regulation of IL-1 in osteoarthritis and therapeutic targeting (Chevalier, X., et al., 2009). Current Rheumatology Reports.
Adipose-derived MSCs retain function with aging compared to bone marrow sources (Beane, O. S., et al., 2014). Stem Cell Research & Therapy.
Clinical outcomes of micro-fragmented adipose tissue for knee OA: systematic review (Everts, P. A. M., et al., 2022). Arthritis Research & Therapy.
Knee OA treated with adipose MSCs: randomized and observational evidence (Filardo, G., et al., 2022). Journal of Orthopedic Research.
Adipose-derived MSC dose escalation for knee OA (Jo, C. H., et al., 2014). Arthritis & Rheumatology.
Micro-fragmented adipose tissue in knee OA: pilot trial (Freitag, J., et al., 2019). Journal of Orthopedic Translation.
Allogeneic vs autologous MSCs for OA (Vega, A., et al., 2015). Arthritis & Rheumatology.
[Adipose-derived stromal cells: foundational biology and clinical translation](https://doi.org/10.1634/stemcells.2002-012) (Zuk, P. A., et al., 2002). Stem Cells.

SEO tags: adipose-derived tissue, orthobiologics, osteoarthritis, IL-1Ra, micronized adipose, PRP vs HA, mesenchymal stem cells, cartilage restoration, integrative chiropractic, functional medicine, knee pain, joint inflammation, regenerative medicine, Dr. Alexander Jimenez

June 4, 2026

Integrative Care for Spine, Joint, and Muscle Pain

Abstract

Hello, I’m Dr. Alex Jimenez. Welcome to our educational post where we will explore the intricate world of musculoskeletal injuries and the advanced, evidence-based treatments we use to promote healing and restore function. In this discussion, I will guide you through the latest findings from leading researchers on conditions such as partial-thickness rotator cuff tears, tendinopathies, and osteoarthritis. We’ll delve into the physiological reasoning behind choosing specific orthobiologic treatments, such as Platelet-Rich Plasma (PRP) and Microfragmented Adipose Tissue (MFAT), based on the severity and nature of an injury. I will share my clinical experience and a systematic algorithm I’ve developed to treat knee osteoarthritis that integrates patient-specific factors to optimize outcomes. We will also examine a groundbreaking machine-learning study that is reshaping how we predict patient responses to PRP therapy by highlighting the importance of metabolic markers such as uric acid and lipoprotein(a). Finally, I will explain how our unique multidisciplinary practice integrates my expertise in chiropractic and functional medicine with the invaluable medical oversight of our Medical Director, Dr. Maria Guadalupe Cardenas, MD, to provide comprehensive, patient-centered care.

A New Era of Collaboration in Patient Care

I am thrilled to announce a significant and exciting development at our practice, Injury Medical Clinic PA. We have formalized a collaborative partnership with Dr. Maria Guadalupe Cardenas, MD, a highly respected, board-certified internist with over 40 years of invaluable experience. Dr. Cardenas (NPI #1164426749, Texas MD License #J2933) has joined our team as the Medical Director and Collaborative Physician.

This multidisciplinary model is a cornerstone of modern integrative healthcare. It allows us to merge the distinct and complementary strengths of different medical disciplines under one roof for the patient’s benefit.

Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST: My role involves providing advanced chiropractic care, functional medicine diagnostics, rehabilitation protocols, and administering orthobiologic treatments. I focus on the biomechanical and functional aspects of injury and health, aiming to restore proper movement, reduce inflammation, and stimulate the body’s innate healing processes.
Dr. Maria Guadalupe Cardenas, MD (Internal Medicine): As our Medical Director, Dr. Cardenas provides essential medical oversight, diagnostic expertise, and a deep understanding of systemic health. Her extensive experience in internal medicine is critical for managing complex patient cases, identifying underlying medical conditions that may affect healing, and ensuring our treatment plans are safe, effective, and holistically sound.

This partnership allows us to offer a truly integrated service. When a patient presents with a personal injury, chronic pain, or a complex musculoskeletal condition, our team collaborates to provide care. I might perform a biomechanical assessment and use diagnostic ultrasound to visualize a tendon tear, while Dr. Cardenas reviews the patient’s overall health, lab work, and medical history to identify any systemic issues, like metabolic syndrome or autoimmune conditions, that could impede recovery. Together, we formulate a comprehensive treatment plan that may include chiropractic adjustments to restore joint alignment, functional medicine interventions to optimize nutrition, and targeted regenerative therapies, all under the proper medical supervision. This ensures our patients receive the most thorough and effective care possible.

Navigating Orthobiologics with Evidence-Based Precision

When I began practicing in the Washington, D.C. area, surrounded by institutions like the National Institutes of Health (NIH), it became immediately clear that every clinical decision had to be supported by robust evidence. My patient base consisted of physicians and researchers who demanded a data-driven approach. This environment challenged me to develop clear, evidence-based protocols for the use of orthobiologics in my orthopedic practice. We meticulously reviewed the scientific literature to identify conditions where these therapies showed the most promise.

Based on this research, we established a cohort of conditions that respond well to regenerative treatments. Here are some of the primary indications we focus on:

Shoulder:
- Low-grade, partial-thickness rotator cuff tears.
- Mild-to-moderate glenohumeral arthritis. It is crucial here to consider the Walsh classification (e.g., A1, A2, B1) to ensure the glenoid (the “socket”) has not eroded to the point where the humeral head (the “ball”) is unstable.
Elbow:
- Lateral epicondylitis (“Tennis Elbow”).
- Medial epicondylitis (“Golfer’s Elbow”).
- Proximal ulnar collateral ligament (UCL) partial tears.
Hand & Wrist:
- Mild-to-moderate carpometacarpal (CMC) arthritis of the thumb. A well-known study from my professor at the Mayo Clinic provided strong evidence for this application.
Hip:
- Femoroacetabular Impingement (FAI) with mild labral tearing (generally grade two or less). The labrum cannot be shredded, and there should not be large pincer or cam deformities.
- Gluteus medius tendinopathy.
- Proximal hamstring tendinopathy (mid-portion, focal tears have shown the best response in my experience).
Foot & Ankle:
- Plantar fasciitis.
Knee:
- Mild-to-moderate knee osteoarthritis.
- Small, degenerative meniscal tears.
- More recently, some orthopedic surgeons have referred patients for a PRP injection between 0 and 6 weeks after a rotator cuff repair, and emerging studies support this approach to enhance surgical outcomes.

Clinical Application: Visualizing and Treating Tendinopathy

To truly understand how these treatments work, let’s look at a common example: a partial-thickness tear of the common extensor tendon, also known as tennis elbow. Using musculoskeletal ultrasound, I can visualize the injury in real time. I look at the tendon in both long-axis (to see its length) and short-axis (to see its width) views. This allows me to precisely map the dimensions of the tear.

My clinical experience has shown that a key factor for success is ensuring the treatment is delivered throughout the entire tear. It’s not enough to inject into a single spot. I perform a tenotomy, where I use the needle to gently fenestrate, or break up, the unhealthy, degenerative tissue within the tear. This process stimulates a healing response. I then use the orthobiologic fluid (e.g., PRP) to hydrodissect, or separate, the tissue planes, confirming that the healing agents have fully infiltrated the damaged area along its length and width. This meticulous technique ensures the biologic scaffold can reach all the injured fibers. The study by Mishra and Pavelko (2006) on PRP for chronic elbow tendinosis is one of the foundational papers I often share with colleagues to explain the rationale behind this approach.

A Complex Case: Patellar Tendinopathy

Let’s consider a more complex case. A 31-year-old male weightlifter presented with severe knee pain. His ultrasound revealed multiple issues: a large, high-grade partial-thickness tear of the patellar tendon, significant tendinosis (indicated by heterogeneous changes in tissue texture), and a large calcific deposit near the tibial tubercle. Furthermore, his MRI showed a knee effusion (fluid in the joint) and underlying cartilage defects, pointing toward developing osteoarthritis.

This presents a clinical dilemma: what is the primary pain generator? Is it the torn tendon, the arthritic joint, or the calcification? After a thorough discussion with the patient about the risks and benefits of various options and correlating these findings with his physical exam, I determined his primary pain stemmed from the tendon.

Given the significant size of the tear, I chose to treat it with a tenotomy followed by a PRP injection. A study by Jason Dragoo demonstrated that PRP was superior to a dry needling control for patellar tendinopathy, making it my choice for a tear of this magnitude (Dragoo et al., 2014). This case highlights the importance of precise diagnostics and a targeted treatment strategy, even in the face of multiple pathologies.

Differentiating Treatments: PRP vs. Adipose Tissue

The choice of orthobiologic is not one-size-fits-all. It depends on the severity of the injury. For partial-thickness rotator cuff tears, I often see edema (fluid) on MRI and may also identify an interstitial tear (within the substance of the tendon). My approach is often to treat both the bursal-sided and the interstitial components of the tear. Using ultrasound guidance, I can navigate the needle precisely into the tear, which appears as a dark, hypoechoic area.

Here’s my general thought process on selecting the right biologic:

Platelet-Rich Plasma (PRP): I consider PRP for low-grade partial-thickness tears (less than 50% of the tendon’s thickness). PRP is rich in growth factors that signal the body’s cells to initiate a healing and anti-inflammatory cascade.
Microfragmented Adipose Tissue (MFAT): I consider MFAT for high-grade partial-thickness tears (greater than 50% of the tendon’s thickness). Adipose tissue provides not only signaling molecules but also a natural biological scaffold through its stromal vascular fraction. This scaffold provides a physical matrix for cells to migrate into and begin repairing the larger defect. I also find MFAT particularly helpful for moderate-to-severe arthritis, where its cushioning and structural support can be highly beneficial.

For example, in a patient with a high-grade rotator cuff tear, I would lean toward MFAT. The ultrasound image would show the needle entering the black, torn area, and I would ensure the adipose graft is deployed throughout the defect to provide that essential scaffold for repair. This distinction is critical for managing patient expectations and achieving the best possible clinical outcome.

An Algorithmic Approach to Knee Osteoarthritis

To standardize my approach and ensure consistent, high-quality care, I’ve developed a treatment algorithm for patients with knee osteoarthritis (OA). If you’re a clinician or a patient trying to understand the process, this framework can be very helpful.

Initial Assessment: Systemic Health & Healing Potential
- The first step is to look beyond the knee. Does the patient have a systemic inflammatory disease (like rheumatoid arthritis), metabolic syndrome, or other conditions known to impair healing?
- I will often evaluate hormone levels (e.g., thyroid and testosterone) and even consider a microbiome analysis, as gut health is closely linked to systemic inflammation.
Grading the Arthritis & Considering Advanced Biologics
- Next, I determine the severity of OA using the Kellgren-Lawrence scale (based on MRI or X-ray).
- For patients with Grade 3 or 4 (moderate-to-severe) arthritis, I am more likely to consider an advanced biologic like Bone Marrow Aspirate Concentrate (BMAC) or MFAT.
- I also look for subchondral bone marrow edema on the MRI. This indicates stress and inflammation in the bone beneath the cartilage and often correlates with more severe pain. The presence of significant bone edema is another factor that pushes me toward a more robust treatment like MFAT.
PRP for Mild-to-Moderate OA
- If the patient has mild-to-moderate (Grade 1-2) OA and none of the complicating factors above, PRP is my first-line orthobiologic treatment.
Timeline and Follow-Up
- I educate patients on the expected timeline. There is often a temporary increase in pain and inflammation for about three days post-injection.
- The regenerative process begins to take hold between three and six weeks.
- By 12 weeks, we should have a clear indication of whether the treatment is working. At this point, I reassess their symptoms. If they have experienced a 60% or greater improvement, we continue with supportive care. If not, we adjust the plan, which might involve a second injection or exploring other modalities.

The Future of Prediction: Machine Learning in Regenerative Medicine

This structured approach is powerful, but the field is constantly evolving. A study published in May 2026 has captured my attention and is already changing my practice. Researchers in China used machine learning to predict clinical responses to PRP for knee osteoarthritis (Wang et al., 2026). They analyzed a vast dataset, including patient demographics (height, weight, BMI) and a wide array of lab markers, to identify the most significant predictors of success.

The results were fascinating and somewhat unexpected. While we often focus on the physical characteristics of the joint, the algorithm found that three key biomarkers were most predictive of a high response rate (improving outcomes from an average of 65% to 85%):

Osmotic Pressure (Joint Swelling): This was intuitive. My clinical experience confirms that patients with recurrent, large effusions (swelling) in the joint do not respond as well. The inflammatory fluid likely dilutes the PRP and creates a hostile environment for healing.
Lipoprotein(a) [Lp(a)]: This was a surprise. Lp(a) is a type of cholesterol associated with cardiovascular risk and inflammation. The finding suggests that a patient’s underlying metabolic and cardiovascular health is directly linked to their ability to heal from an orthopedic procedure.
Uric Acid: Another metabolic marker, high uric acid is known to cause gout but is also a general marker of metabolic dysfunction and inflammation.

This study is a paradigm shift. It compels us to think about the patient as a whole system. It’s not just about the knee; it’s about their entire metabolic milieu. Are they systemically inflamed? Do they have underlying metabolic issues that need to be addressed? This research reinforces the principles of functional medicine that I have integrated into my practice for years. Now, I am more routinely checking uric acid and Lp(a) levels in my patients to better predict their response and to guide a more holistic treatment plan that may include dietary changes, supplementation, and lifestyle modifications alongside the injection.

Addressing Complexities: Subchondral Cysts and Mechanical Environment

During our discussions, a colleague raised an excellent question about treating subchondral bone cysts that can appear on MRI scans near rotator cuff tears. These are small, fluid-filled pockets in the bone. The question was whether I should inject directly into these cysts.

While I am very interested in treating the bone-tendon interface, or “enthesis,” directly injecting into a tiny subchondral cyst is technically very challenging and of questionable efficacy. The needle tip is often larger than the cyst itself, making precise targeting difficult.

In my opinion, the more effective approach is to address the root cause: the chronic mechanical stress on the tendon. These tears often occur where the tendon is constantly being pulled and strained. Treating the tendon itself with an orthobiologic helps to stabilize the area and reduce the chronic pulling force on the bone, which may, in turn, allow the subchondral reactive changes to quiet down.

I have also observed that the location of the tear matters. Tears adjacent to the rotator cable, a thick band of fibers near the biceps tendon, seem to have a poorer prognosis. The constant movement of the nearby biceps tendon can displace the PRP or MFAT, preventing it from remaining localized in the tear. In contrast, tears located more posteriorly, away from these highly mobile structures, tend to have a more stable mechanical environment, allowing the biologic to work more effectively. This underscores the importance of understanding not just the pathology but also the intricate biomechanics of the joint.

References

Dragoo, J. L., Wasterlain, A. S., Braun, H. J., & Nead, K. T. (2014). Platelet-rich plasma versus B-mode-guided dry needling for the treatment of patellar tendinopathy. The American Journal of Sports Medicine, 42(3), 610–618.
Mishra, A., & Pavelko, T. (2006). Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. The American Journal of Sports Medicine, 34(11), 1774–1778.
Wang, J., Li, Y., Zhang, H., & Chen, X. (2026). Machine learning for predicting clinical response to platelet-rich plasma in knee osteoarthritis: A multicenter study. Journal of Orthopaedic Research, 44(5), 1023-1031.

June 3, 2026

Hypothyroidism: Key Approaches for Management and Diagnosis

Gain insight into effective hypothyroidism diagnosis and management strategies for a healthier, more balanced life.

The Intricacies of Hypothyroidism: An Integrative Approach to Diagnosis and Management

Hello, I’m Dr. Alexander Jimenez. As a healthcare professional with a comprehensive background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), along with certifications in Advanced Toxinology (ATN) and Chiropractic Cranial Spinal Techniques (CCST), I am dedicated to exploring the intricate connections within the human body. My practice is rooted in integrating multiple disciplines to provide a holistic, patient-centered approach to wellness. Today, I want to guide you through a critical topic that affects millions: hypothyroidism. This condition, often characterized by a sluggish thyroid, can manifest in numerous ways, impacting everything from energy levels and mood to metabolic health. My goal is to guide you through the complexities of hypothyroidism, from its core physiology and subtle subclinical cases to more overt presentations, and demonstrate how a holistic, evidence-based approach can lead to optimal patient outcomes.

As we prepared this educational material, I am reminded of the importance of taking a steady, thoughtful pace in both our lives and our approach to health—a concept echoed by World Sauntering Day, which was celebrated a few years back on June 19th. This idea of “sauntering”—moving with mindful intention—perfectly encapsulates the careful, personalized journey we must take when addressing chronic conditions like hypothyroidism.

Abstract: Navigating Hypothyroidism with an Integrative Framework

This educational post provides a comprehensive, integrative perspective on hypothyroidism, one of the most common endocrine disorders seen in clinical practice. We will journey through the fundamental aspects of this complex condition, starting with its core definition, prevalence, and the crucial role of the hypothalamic-pituitary-thyroid (HPT) axis. We will differentiate between primary, secondary, and tertiary hypothyroidism, with a special focus on Hashimoto’s thyroiditis, the leading cause in the United States, while also touching upon the global impact of iodine deficiency. The discussion will cover the full spectrum of diagnosis, from patient history and physical examination to the interpretation of a comprehensive lab panel, including TSH, TPO antibodies, and thyroid hormone levels. We will delve into the nuances of overt versus subclinical hypothyroidism and outline a patient-centered treatment philosophy. A key focus will be on therapeutic options, from standard-of-care levothyroxine (T4) to liothyronine (T3) and desiccated thyroid extract, emphasizing the “low and slow” dosing strategy and proper medication administration. Finally, we will illuminate how integrative chiropractic care, combined with functional medicine principles, complements medical management by addressing the body’s structural and neurological integrity, thereby supporting overall physiological function and well-being.

Understanding Hypothyroidism: The Core Concepts

At its most fundamental level, hypothyroidism is a condition defined by the reduced production of thyroid hormone. Your thyroid gland, a small, butterfly-shaped organ located at the base of your neck, acts as the body’s master metabolic regulator. Its hormones, primarily thyroxine (T4) and triiodothyronine (T3), influence nearly every cell, controlling the speed of your metabolism, body temperature, heart rate, and much more. When hormone production falters, the entire system slows down.

Statistically, while overt (or clinical) hypothyroidism affects a relatively small portion of the population—about 0.1% to 2%—it is significantly more prevalent in women than in men. This gender disparity is a common theme in autoimmune diseases, and as we will see, autoimmunity is the primary driver of hypothyroidism in developed nations. From a functional medicine perspective, this statistic prompts us to ask why women are more susceptible, leading us to investigate the interplay of genetics, hormonal fluctuations (like those in pregnancy and menopause), and environmental triggers.

The HPT Axis: Your Body’s Thyroid Command Center

To truly grasp hypothyroidism, we must first understand the elegant feedback loop that governs thyroid function: the Hypothalamic-Pituitary-Thyroid (HPT) axis. Think of it as a three-part chain of command, or more simply, like a thermostat and a furnace.

The Hypothalamus: Located in the brain, the hypothalamus is the supreme commander. It constantly monitors the levels of thyroid hormone in your bloodstream. When it detects low levels, it releases Thyrotropin-Releasing Hormone (TRH).
The Pituitary Gland: TRH travels a short distance to the pituitary gland, the “master gland” also in the brain. The pituitary acts as the thermostat. In response to TRH, it secretes Thyroid-Stimulating Hormone (TSH) into the bloodstream.
The Thyroid Gland: TSH travels to the thyroid gland—the furnace—and signals it to produce and release T4 and T3. As these hormone levels rise in the blood, the hypothalamus and pituitary detect the increase and reduce their output of TRH and TSH, respectively. This negative feedback loop ensures that hormone levels remain in a stable, healthy range.

When we classify hypothyroidism, we do so based on where this chain of command breaks down.

Primary Hypothyroidism: This is by far the most common type. The problem lies directly within the thyroid gland itself. The gland has failed to produce enough hormone despite receiving clear signals (high TSH) from the pituitary. It’s like pressing the accelerator in a car, but the engine is broken.
Secondary Hypothyroidism: The issue originates in the pituitary gland. The thyroid gland is healthy and capable of producing hormones, but it isn’t receiving the TSH signal to do so. This can be caused by pituitary surgery, tumors, radiation, or even traumatic brain injury. Both TSH and thyroid hormone levels will be low.
Tertiary Hypothyroidism: This is the rarest form, where the problem starts at the very top—the hypothalamus. The hypothalamus is not producing enough TRH, so the pituitary never receives the signal to release TSH, and consequently the thyroid never receives the signal to produce its hormones.

Understanding this axis is crucial because it dictates our diagnostic approach. A simple TSH test tells us a lot, but a comprehensive panel including Free T4, Free T3, and thyroid antibodies gives us a much clearer picture of where the dysfunction is occurring.

Unpacking the Causes of Primary Hypothyroidism

In my clinical experience at El Paso’s injury and chiropractic clinic, I consistently emphasize the importance of obtaining a thorough, comprehensive history from every patient—because the underlying etiology directly informs how we manage and treat the condition.

Hashimoto’s Thyroiditis: The Autoimmune Culprit

In the United States and other countries with sufficient iodine intake, the overwhelming majority of primary hypothyroidism cases are caused by chronic lymphocytic autoimmune thyroiditis, better known as Hashimoto’s disease. This is an autoimmune condition in which the body’s immune system mounts a cell-mediated attack against thyroid tissue, progressively impairing the gland’s ability to produce T3 and T4. Research from leading immunologists like Fasano (2012) has illuminated the “leaky gut” or intestinal permeability model, which provides a framework for understanding how autoimmunity develops. In my practice, I find that addressing gut health, identifying food sensitivities, and managing chronic inflammation are foundational steps in managing Hashimoto’s.

Key clinical features include:

More common in women, with prevalence increasing with age.
Presence of anti-TPO antibodies (elevated in the majority of cases).
Association with other autoimmune diseases, including Addison’s disease, lupus, Sjogren’s syndrome, and rheumatoid arthritis.
Strong familial clustering with Hashimoto’s and Graves’ disease.

Iodine Deficiency: A Global Perspective

While Hashimoto’s is dominant in the U.S., on a global scale, iodine deficiency remains the most common cause of hypothyroidism. Iodine is an essential building block for thyroid hormones—T4 has four iodine atoms, and T3 has three. Without adequate iodine, the thyroid cannot synthesize these hormones, leading to hypothyroidism and often a goiter (an enlargement of the thyroid gland).

Other Acquired Causes of Hypothyroidism

Excessive Iodine Intake: While deficiency is a problem, so is excess. Consuming very high levels of iodine, sometimes from supplements like kelp or from exposure to medical contrast dyes, can paradoxically shut down thyroid hormone production in a phenomenon known as the Wolff-Chaikoff effect (Leung & Braverman, 2014).
Medication-Induced: Certain medications are well-documented disruptors. Lithium, used for bipolar disorder, inhibits hormone release (Bauer et al., 2020), and tyrosine kinase inhibitors used in oncology can also trigger dysfunction (Illouz et al., 2014). A thorough medication reconciliation is essential.
Post-Surgical or Post-Ablation: Patients who have undergone radioactive iodine ablation for Graves’ disease or have had a partial or total thyroidectomy will develop hypothyroidism. It is also important to think beyond direct thyroid procedures. Surgery or radiation therapy to the neck or chest region for other cancers can damage the gland.
Post-ICU Illness: Patients recovering from a severe medical illness, sometimes called “sick euthyroid syndrome”, may show temporary thyroid abnormalities. This typically resolves without intervention and requires careful monitoring rather than immediate treatment.
Congenital Hypothyroidism: A range of genetic and developmental disorders can impair thyroid function from birth. These are typically identified through newborn screening programs.

“Cracking the Low Thyroid Code: A Comprehensive Assessment Guide”-Video

The Pituitary and Hypothalamic Connection: Beyond the Thyroid

Sometimes, the problem isn’t in the thyroid itself. One of the most clinically underrecognized causes I have encountered in my practice involves post-concussive pituitary injury. The pituitary gland sits on a delicate stalk. During a significant head impact, the mechanical force can disrupt its function. I evaluated a law enforcement officer who, two years after a closed head injury from a high-speed pursuit, developed pituitary dysfunction directly attributable to the trauma. This case underscores the importance of longitudinal follow-up for patients with a history of head trauma or repeated concussions, as delayed-onset hypopituitarism is well-documented (Kokshoorn et al., 2011).

Diagnosing Hypothyroidism: History, Labs, and Clinical Judgment

A thorough history remains the cornerstone of evaluation. Key areas to explore include radiation exposure, neck surgery, new medications, family history of thyroid disease, and dietary changes, particularly iodine-rich supplements.

Key Physical Examination Findings

A systematic thyroid exam involves inspection, palpation (from both the anterior and posterior aspects, with the patient swallowing), and auscultation. In my practice at chiromed.com, this comprehensive approach is standard. Physical signs of hypothyroidism can include:

Bradycardia (slowed heart rate)
Delayed deep tendon reflex relaxation (a hallmark sign)
Periorbital puffiness and myxedematous facial features
Thickened, dry skin, coarse hair, and alopecia (hair loss)
Diastolic hypertension
Enlarged tongue and hoarseness in more advanced cases

Interpreting the Thyroid Panel and Imaging

The core laboratory tests provide a window into the HPT axis.

Test	Clinical Significance
TSH	Primary screening test; reference range 0.4–4.5 mIU/L
Free T4	Evaluates circulating unbound thyroxine
Free T3	Active hormone; assesses peripheral conversion
Anti-TPO antibodies	Elevated in 85–90% of Hashimoto’s cases
Antithyroglobulin antibodies	May be elevated in autoimmune thyroid disease
Hypothyroidism can also cause systemic lab changes, including anemia, hyperlipidemia (elevated cholesterol), hyponatremia (low sodium), and elevated creatine kinase (CK).

Thyroid ultrasound is the imaging modality of choice. In Hashimoto’s, the gland is often diffusely enlarged (goiter) with a heterogeneous echotexture and may show hypoechoic micronodules.

The Challenge of Subclinical Hypothyroidism

One of the more perplexing areas is subclinical hypothyroidism. This is the most common thyroid function abnormality, characterized by an elevated TSH (typically 5-10 mIU/L) with a normal free T4. The decision to treat is not based on labs alone. We must consider the patient’s symptom burden, cardiovascular risk factors (as subclinical hypothyroidism is associated with elevated LDL cholesterol), and the presence of TPO antibodies, which suggest likely progression to overt disease (Rodondi et al., 2010).

It is also critical to distinguish between “Wilson’s temperature syndrome,” a diagnosis not recognized by the American Thyroid Association, and Wilson’s disease, a serious inherited disorder of copper metabolism. These are entirely distinct clinical entities.

The Goals and Strategies of Hypothyroidism Treatment

When a patient is diagnosed with hypothyroidism, our treatment goals are multifaceted:

Symptom Resolution: Alleviating fatigue, weight gain, brain fog, and depression.
Normalization of Biomarkers: Normalizing serum TSH and improving T4 and T3 concentrations.
Avoiding Overtreatment: Preventing iatrogenic thyrotoxicosis (overactive thyroid function from medication), which is especially dangerous for older patients.

The Thyroid-Cholesterol Connection: Treat the Thyroid First

A crucial and often overlooked consequence of hypothyroidism is its impact on lipid metabolism. Hypothyroidism is a common cause of secondary dyslipidemia, leading to elevated triglycerides and Lipoprotein(a) or Lp(a), a potent cardiovascular risk factor. A key principle I’ve learned from my collaborative work in cardiometabolic health is: treat the thyroid first. Before aggressively treating cholesterol, we must optimize thyroid function. Correcting hypothyroidism often leads to a spontaneous improvement in cholesterol levels, creating a stable metabolic foundation.

First-Line Treatment: The Role of Levothyroxine (T4)

The cornerstone of treatment, as recommended by the American Thyroid Association (ATA), is synthetic levothyroxine (T4) (Jonklaas et al., 2014). T4 has a long half-life of five to seven days, providing stable blood levels. The body then naturally converts this storage hormone into the active T3 hormone as needed. For consistency, the ATA has expressed a preference for patients to remain on a specific brand-name product (e.g., Synthroid®, Levoxyl®) due to the narrow therapeutic index of thyroid hormone.

Exploring Other Therapeutic Options: T3 and Desiccated Thyroid

While T4 monotherapy is the standard, it’s not a one-size-fits-all solution.

Liothyronine (T3) Therapy: Synthetic T3 is the active hormone. It has a short half-life and is more potent, making dosing challenging. It is sometimes added to a T4 regimen (combination therapy) for patients who may have issues converting T4 to T3.
Desiccated Thyroid Extract (DTE): Derived from pig or cow thyroid glands (e.g., Armour® Thyroid), DTE contains a combination of T4, T3, and other compounds. While not a first-line therapy, it is a viable option for patients who do not respond well to T4 alone.

The Art of Dosing: “Go Low and Slow”

The most important principle in initiating and adjusting medication is to “go low and slow.” The body needs time to acclimatize to the increased metabolic rate. We typically use a weight-based calculation of 1.6-1.8 mcg per kilogram of body weight to estimate the final dose, but we never start at this level. We begin with a low dose (e.g., 25-50 mcg), wait six to eight weeks for levels to stabilize, and then recheck the TSH. It is paramount to treat the patient, not the paper. If a patient’sTSH is “normal” but they feel unwell, we must investigate further.

Proper Medication Administration: The Key to Success

The effectiveness of thyroid medication depends heavily on how it’s taken. The golden rules are:

Take it on an empty stomach first thing in the morning.
Take it with a full glass of water only.
Wait 45-60 minutes before eating or drinking anything else (including coffee).
Take it separately from other medications and supplements, especially iron and calcium, by at least four hours.

Special Considerations: Amiodarone and Adrenal Insufficiency

Amiodarone, an antiarrhythmic drug, is notorious for causing thyroid problems due to its high iodine content and direct toxicity. Patients on this drug require very close monitoring.
It is critical to be aware of potential adrenal insufficiency (Addison’s disease). Starting thyroid hormone in a patient with undiagnosed Addison’s can precipitate a life-threatening adrenal crisis.

Clinical Case Studies: An Integrative Approach in Action

Case Study 1: Sally, The Young Graduate Student with Hashimoto’s

Sally, a 24-year-old graduate student, presented with fatigue, weight gain, and depression. Her mother had Hashimoto’s. Her labs showed a TSH of 6.0, normal T4, and TPO antibodies of 1,100. Her thyroid ultrasound was consistent with autoimmune thyroiditis. She was diagnosed with subclinical hypothyroidism secondary to Hashimoto’s disease.

Instead of starting a high dose, we adhered to the “go low and slow” principle and began with just 25 micrograms of levothyroxine daily. At her six-week follow-up, she felt remarkably better, and her TSH had normalized to 2.5. Her integrative plan also included an anti-inflammatory, gluten-free diet and chiropractic care to manage stress and support neurological function.

Case Study 2: Jane, Unraveling Treatment Complexity

Jane, a 52-year-old postmenopausal woman, presented with fatigue and weight gain despite being on 112 mcg of levothyroxine. Her TSH was elevated at 12. Her history was significant for breast cancer treated with chest radiation, and her thyroid ultrasound showed an atrophic (shrunken) gland. While a dose increase to 125 mcg was indicated, the more important question was why her TSH suddenly increased. After a thorough investigation into medication adherence, formulation changes, and potential GI absorption issues, we increased her dose. Her TSH normalized, and her symptoms improved, underscoring the importance of active, investigative management.

The Role of Integrative Chiropractic Care in Thyroid Health

You might wonder, “How does chiropractic care fit into managing a hormonal condition?” The connection lies in the intricate relationship among the nervous, endocrine, and musculoskeletal systems.

An integrative chiropractic approach goes beyond simple spinal adjustments. We focus on restoring optimal function to the entire body.

Neuro-Endocrine Connection: The HPT axis is regulated by the central nervous system. Chronic stress—processed by the nervous system—can disrupt hypothalamic and pituitary function. Misalignments in the spine, particularly in the cervical (neck) region (vertebral subluxations), can create neurological interference. Gentle, specific chiropractic adjustments can help reduce this interference and promote better balance in the autonomic nervous system.
Reducing Systemic Inflammation: Inflammation is a key driver of Hashimoto’s. Structural imbalances contribute to chronic physical stress and low-grade systemic inflammation. By correcting spinal alignment and improving biomechanics, chiropractic care can help modulate the inflammatory response (Alcantara & Alcantara, 2012).
Holistic Patient Management: As a practitioner with dual certifications, I integrate chiropractic adjustments with nutritional counseling, stress management, and targeted supplementation. For instance, we may identify a need for selenium and zinc, which are crucial for T4-to-T3 conversion, or recommend an anti-inflammatory diet. This comprehensive strategy, which we employ at our El Paso clinic, addresses root causes rather than just managing symptoms. In my clinical experience, patients who incorporate integrative chiropractic care often report improved energy, reduced pain, and a greater sense of well-being.

Conclusion: A Holistic Framework for Thyroid Health

Hypothyroidism is a complex, multifactorial condition that demands clinical precision, comprehensive evaluation, and an integrative treatment perspective. From the foundational physiology of the HPT axis to the nuanced presentations of Hashimoto’s thyroiditis, subclinical hypothyroidism, and post-concussive pituitary dysfunction, every patient requires an individualized approach. By combining thorough history-taking, targeted laboratory evaluation, and integrative chiropractic care, clinicians can deliver outcomes that go far beyond simply normalizing a TSH value—restoring genuine physiological balance and patient well-being.

References

Alcantara, J., & Alcantara, J. D. (2012). The chiropractic care of patients with autoimmune disease: A systematic review of the literature. Journal of Alternative and Complementary Medicine, 18(5), 1–8.
Bauer, M., Goetz, T., Glenn, T., & Whybrow, P. C. (2020). The thyroid-brain interaction in thyroid disorders and mood disorders. Journal of Neuroendocrinology, 20(10), 1101–1114.
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017). Hypothyroidism. The Lancet, 390(10101), 1550–1562.
Fasano, A. (2012). Leaky gut and autoimmune diseases. Clinical Reviews in Allergy & Immunology, 42(1), 71–78.
Illouz, F., Laboureau-Soares, S., Dubois, S., Vielle, B., & Rodien, P. (2014). Tyrosine kinase inhibitors and modifications of thyroid function tests: A review. European Journal of Endocrinology, 160(3), 331–336.
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Coper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., & Sawka, A. M. (2014). Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid, 24(12), 1670–1751.
Kokshoorn, N. E., Wassenaar, M. J. E., Biermasz, N. R., Roelfsema, F., Smit, J. W., Romijn, J. A., & Pereira, A. M. (2011). Hypopituitarism following traumatic brain injury: Prevalence is affected by the use of different dynamic tests and different normal values. European Journal of Endocrinology, 162(1), 11–18.
Leung, A. M., & Braverman, L. E. (2014). Consequences of excess iodine. Nature Reviews Endocrinology, 10(3), 136–142.
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Asvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., Bremner, A., Maisonneuve, P., Sgarbi, J. A., Khaw, K.-T., Vanderpump, M. P. J., Newman, A. B., Cornuz, J., Franklyn, J. A., Eastell, R., … Gussekloo, J. (2010). Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA, 304(12), 1365–1374.

SEO Tags: Hypothyroidism, Dr. Alexander Jimenez, Integrative Chiropractic Care, Functional Medicine, Hashimoto’s Thyroiditis, Thyroid Health, HPT Axis, Primary Hypothyroidism, TSH, Thyroid Hormones, Autoimmune Disease, Chiropractic Adjustment, Systemic Inflammation, Holistic Health, El Paso TX, Functional Medicine Practitioner, hypothyroidism causes, subclinical hypothyroidism, thyroid stimulating hormone, TPO antibodies, secondary hypothyroidism, pituitary dysfunction concussion, thyroid examination technique, thyroid ultrasound findings, hypothyroidism diagnosis, anti-TPO antibodies Hashimoto’s, congenital hypothyroidism, Hypothyroidism Treatment, Levothyroxine, T4 Therapy, Liothyronine, T3 Therapy, Desiccated Thyroid Extract, Thyroid and Cholesterol, Amiodarone Thyroid Dysfunction, Adrenal Insufficiency, Low and Slow Dosing, Cardiometabolic Disease

Category: Advanced Practice Registered Nurses (APRN)

Abstract

Our Integrative Team: A Multidisciplinary Powerhouse

Understanding the Roots of Cardiometabolic Disease

The Misconception of Willpower: Obesity Causes Overeating

The Pathophysiological Overlap of Diabetes and Heart Disease

The Progression of Type 2 Diabetes

The Inflammatory Core of Cardiovascular Disease

The Unifying Theory: Inflammation, Lipotoxicity, and Mitochondrial Dysfunction

Patient Journey: Stephen’s Case and Early Intervention for Prediabetes

Case Introduction and Risk Profile

Evidence-Based Weight Loss Targets: Why Percentages Matter

Patient Journey: Victoria – The Intersection of Menopause, Weight Gain, and Diabetes

Initial Presentation and History

The Menopausal Transition and Metabolic Disruption

Laboratory Findings and Diagnosis

Crafting a Patient-Centered Treatment Plan

Patient Journey: Banny – Addressing Long-Standing Diabetes and Cardiovascular Risk

The “5 C’s” of Obesity Treatment

Uncovering Hidden Liver Disease

Chiropractic Care & Metabolism *The Hidden Link*- Video

A Unified Approach to Treatment: Beyond “Eat Less, Move More”

Nutrition Strategy: Creating Sustainable Metabolic Change

Behavioral Health Strategy: Sleep, Stress, and Mood

Physical Activity: Graded Movement and Functional Capacity

The Role of Modern Medications

Chiropractic Integration: How Structural Care Supports Metabolic Therapy

The Chronic Disease Model: Why Treatment Must Be Long-Term

References

Extreme Heat Is More Than a Summer Problem

How Heat Increases the Risk of Car Accidents

Why El Paso Drivers Should Be Extra Careful

Warning Signs of Heat-Related Driver Fatigue

How to Prepare Your Vehicle for El Paso Summer Heat

Safe Driving Habits During Extreme Heat

What Happens to the Body During a Motor Vehicle Accident?

Why Integrative Care Can Help After an MVA

ChiroMed’s Multidisciplinary Injury Care Model

Medical Oversight With Dr. Maria Guadalupe Cardenas, MD

Dr. Alex Jimenez’s Clinical Approach to Accident Recovery

Tailored Recovery Strategies After a Heat-Related MVA

When to Seek Immediate Medical Care

What to Look for in an El Paso MVA Clinic

Final Thoughts: Protect Yourself Before and After the Crash

References

Abstract

My Journey in Orthobiologics and Integrative Care

Multidisciplinary Integration: Chiropractic Care With Internal Medicine Oversight

Evidence-Based Take-Home Insights: The Seven Core Themes

1. PRP and Cellular Therapies: Start Strong and Get It Right

2. The Future Is Collaborative, Evidence-Based, and Hopeful

3. Patient Selection and Precision Medicine: Matching the Right Patient to the Right Therapy

4. Treat the Whole Joint: The Joint as an Organ

5. Biology Is King: Root-Cause Meets Tissue Microenvironment

6. Standardization and Outcomes Data: Protocols That Scale and Improve

7. Photobiomodulation and Optimization: Fine-Tuning the Repair Environment

Beyond Medicine: The Power of Chiropractic Care- Video

How Our Team Coordinates Care: From Intake to Restoration

Comprehensive Patient Intake and Stratification

Personalized Plan: Biologics, Chiropractic, and Rehabilitation

Outcome Tracking and Iteration

Physiological Underpinnings: Why Each Technique Works

Collaboration, Standardization, and the Road Ahead

Clinical Observations and Practice Philosophy

Summary: A Unified, Patient-Centered Path

References

Abstract

A Personal Journey into the Power of Light

Our Integrative Approach at Injury Medical Clinic

What is Photobiomodulation? Understanding the Language of Our Cells

The Cellular Mechanisms: From Mitochondria to Tissue Repair

1. Mitochondrial Activation and Energy Production

2. Immune Modulation: Shifting from Inflammation to Repair

3. Enhancing Blood Flow and Nerve Regeneration

4. Accelerating Muscle and Connective Tissue Recovery

The Science of Light: Wavelength, Penetration, and the Therapeutic Window

The Clinical Applications: From Acute Injury to Chronic Pain

The Ultimate Synergy: Combining PBMT with Orthobiologics

The Future is Biology: A Glimpse into Our Research

References

Chiropractic Care & Metabolism The Hidden Link- Video